Sigma receptors [σRs]: biology in normal and diseased states
暂无分享,去创建一个
[1] E. López-Bayghen,et al. Glutamate‐induced octamer DNA binding and transcriptional control in cultured radial glia cells , 2006, Journal of neurochemistry.
[2] F. López-Muñoz,et al. Neurobiological Background for the Development of New Drugs in Schizophrenia , 2011, Clinical neuropharmacology.
[3] Teruo Hayashi,et al. σ-1 Receptor Ligands , 2004 .
[4] H. Shannon,et al. Glutamate receptors of the N-methyl-D-aspartate subtype in the myenteric plexus of the guinea pig ileum. , 1989, The Journal of pharmacology and experimental therapeutics.
[5] G. Debonnel,et al. Effects of the Potential Antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone Monomethanesulfonate] a Combined σ and 5-HT1A Ligand: Modulation of Neuronal Activity in the Dorsal Raphe Nucleus , 2004, Journal of Pharmacology and Experimental Therapeutics.
[6] W. Bowen,et al. Highly selective sigma receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes. , 1998, European journal of pharmacology.
[7] D. W. Parish,et al. PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. , 1994, Pharmacology, biochemistry, and behavior.
[8] H Lecar,et al. Cone photoreceptors respond to their own glutamate release in the tiger salamander. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Marc,et al. Patterns of glutamate immunoreactivity in the goldfish retina , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[10] N. Colabufo,et al. F281, synthetic agonist of the sigma-2 receptor, induces Ca2+ efflux from the endoplasmic reticulum and mitochondria in SK-N-SH cells. , 2009, Cell calcium.
[11] G. Glavin,et al. Circumventricular organ origin of domoic acid-induced neuropathology and toxicology , 1991, Brain Research Bulletin.
[12] M. Kavanaugh,et al. Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2-methyl[4,6-3H]phenyl)guanidine. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[13] B. Sakmann,et al. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. , 1990, Science.
[14] K. Borowicz,et al. Influence of 3-PPP, a sigma receptor ligand, on the anticonvulsive action of conventional antiepileptic drugs. , 1999, Pharmacological research.
[15] H. Akil,et al. Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. , 1995, Drug and alcohol dependence.
[16] T. Heffner,et al. The Pharmacology of the Novel and Selective Sigma Ligand, PD 144418 , 1997, Neuropharmacology.
[17] J. Dowling,et al. The excitatory and inhibitory amino acid receptors on horizontal cells isolated from the white perch retina. , 1993, Journal of neurophysiology.
[18] V. Dawson,et al. Neuroprotective effect of σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production , 2001 .
[19] S. Haj-Dahmane,et al. Modulation of the serotonin system by endocannabinoid signaling , 2011, Neuropharmacology.
[20] J. Kemp,et al. Ionotropic and metabotropic glutamate receptor structure and pharmacology , 2005, Psychopharmacology.
[21] T. Su,et al. Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity , 2005, Neuroreport.
[22] E. Calabrese. Opiates: Biphasic Dose Responses , 2001, Critical reviews in toxicology.
[23] Yuchun Gu,et al. Expression of Functional Metabotropic Glutamate Receptors in Primary Cultured Rat Osteoblasts , 2000, The Journal of Biological Chemistry.
[24] Tetsuya Kobayashi,et al. SA4503, a novel cognitive enhancer, with σ1 receptor agonistic properties , 1997, Behavioural Brain Research.
[25] I. Efimov,et al. Site of Origin and Molecular Substrate of Atrioventricular Junctional Rhythm in the Rabbit Heart , 2003, Circulation research.
[26] F. Moroni,et al. The presence of N-methyl-d-aspartate-type receptors for glutamic acid in the guinea pig myenteric plexus , 1986, Neuroscience Letters.
[27] R. Faull,et al. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain , 1997, Neuroscience.
[28] J. Mcdonald,et al. The metabotropic excitatory amino acid receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury. , 1992, European journal of pharmacology.
[29] D. Zamanillo,et al. Regulation of Ionotropic Glutamate Receptor Subunits in Different Rat Brain Areas by a Preferential Sigma1 Receptor Ligand and Potential Atypical Antipsychotic , 2000, Neuropsychopharmacology.
[30] Y. Moriyama,et al. Glutamatergic chemical transmission: look! Here, there, and anywhere. , 2004, Journal of biochemistry.
[31] D. Farb,et al. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. , 1991, Molecular pharmacology.
[32] E. J. Fletcher,et al. Blockade by sigma site ligands of N‐methyl‐D‐aspartate‐evoked responses in rat and mouse cultured hippocampal pyramidal neurones , 1995, British journal of pharmacology.
[33] A. N. van den Pol,et al. GABA receptors precede glutamate receptors in hypothalamic development; differential regulation by astrocytes. , 1995, Journal of neurophysiology.
[34] P. Romieu,et al. Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference. , 2000, Neuroreport.
[35] J. Roberts,et al. Multiple σ binding sites in guinea‐pig and rat brain membranes: G‐protein interactions , 1992 .
[36] T. Maurice,et al. Neuroprotective and anti-amnesic potentials of sigma (sigma) receptor ligands. , 1997, Progress in neuro-psychopharmacology & biological psychiatry.
[37] H. Guizouarn,et al. Cancer Cell Cycle Modulated by a Functional Coupling between Sigma-1 Receptors and Cl– Channels* , 2007, Journal of Biological Chemistry.
[38] S. Yamawaki,et al. Differential regulation by pregnenolone sulfate of intracellular Ca2 increase by amino acids in primary cultured rat cortical neurons , 1998, Neurochemistry International.
[39] W. Bowen,et al. 99mTc-labeled sigma-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells. , 1997, Bioconjugate chemistry.
[40] T. Freund,et al. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia , 2006, Neuroscience.
[41] T. Yamamoto,et al. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[42] R. Matsumoto,et al. Sigma-1 receptors: potential targets for the treatment of substance abuse. , 2012, Current pharmaceutical design.
[43] O. Pulido,et al. Molecular and immunochemical characterization of the ionotropic glutamate receptors in the rat heart , 1998, Brain Research Bulletin.
[44] A. Urani,et al. Enhanced antidepressant effect of sigma(1) (sigma(1)) receptor agonists in beta(25-35)-amyloid peptide-treated mice. , 2002, Behavioural Brain Research.
[45] P. Delmas,et al. Glutamate receptors are expressed by bone cells and are involved in bone resorption. , 1998, Bone.
[46] K. Hashimoto,et al. Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors , 2010, Annals of general psychiatry.
[47] R. Purdy,et al. Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids. , 1997, Molecular pharmacology.
[48] T. Kameyama,et al. Beneficial Effects of Acute and Repeated Administrations of σ Receptor Agonists on Behavioral Despair in Mice Exposed to Tail Suspension , 1998, Pharmacology Biochemistry and Behavior.
[49] C. Parsons,et al. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. , 1998, Pharmacological reviews.
[50] P. Acton,et al. Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent. , 2001, Nuclear medicine and biology.
[51] A. Privat,et al. SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice. , 1997, European journal of pharmacology.
[52] A. Bossuyt,et al. Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical results. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[53] Kathryn Trinkaus,et al. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy , 2007, Molecular Cancer.
[54] H. Hirai,et al. Molecular Determinants of Agonist Discrimination by NMDA Receptor Subunits: Analysis of the Glutamate Binding Site on the NR2B Subunit , 1997, Neuron.
[55] J. Mogil,et al. Antinociception following 1,3,-di-o-tolylguanidine, a selective σ receptor ligand , 1995, Pharmacology Biochemistry and Behavior.
[56] Ruoyan Chen,et al. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain , 2003, Biological Psychiatry.
[57] R. Zatorre,et al. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. , 1990, The New England journal of medicine.
[58] K. Fukunaga,et al. Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions , 2010, Expert opinion on therapeutic targets.
[59] G. Pasternak,et al. (−)-Pentazocine analgesia in mice: interactions with a σ receptor system , 1995 .
[60] S. Stahl. Antidepressant Treatment of Psychotic Major Depression: Potential Role of the σ Receptor , 2005, CNS Spectrums.
[61] P. Masand,et al. Atypical antipsychotics in the treatment of affective symptoms: a review. , 2004, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[62] P. Genever,et al. Evidence for a novel glutamate-mediated signaling pathway in keratinocytes. , 1999, The Journal of investigative dermatology.
[63] R. Rockhold,et al. Excitotoxin-induced myocardial necrosis. , 1989, European journal of pharmacology.
[64] C. Köhler. The distribution of serotonin binding sites in the hippocampal region of the rat brain. An autoradiographic study , 1984, Neuroscience.
[65] S. Okuyama,et al. Amino acid residues in the transmembrane domain of the type 1 sigma receptor critical for ligand binding , 1999, FEBS letters.
[66] J. Fernández-Ruiz,et al. The endocannabinoid system as a target for the treatment of neuronal damage , 2010, Expert opinion on therapeutic targets.
[67] R. Olsen,et al. Molecular biology of GABAA receptors , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[68] Teruo Hayashi,et al. Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[69] J. Rothstein,et al. Glutamatergic Enteric Neurons , 1997, The Journal of Neuroscience.
[70] K. Ault,et al. Cocaine effects on immunocompetent cells: an observation of in vitro cocaine exposure. , 1999, International journal of immunopharmacology.
[71] J. Morley,et al. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[72] Sophie Couture,et al. Modulation of the neuronal response to N‐Methyl‐D‐Aspartate by selective sigma2 ligands , 1998, Synapse.
[73] T. Kosatsky,et al. Amnesic shellfish poisoning: a new clinical syndrome due to domoic acid. , 1990, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada.
[74] W. Bowen,et al. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors. , 1989, FEBS letters.
[75] L. Montoliu,et al. Formalin-induced pain is reduced in σ1 receptor knockout mice , 2005 .
[76] D. Bitrán,et al. Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor , 1991, Brain Research.
[77] Teruo Hayashi,et al. Intracellular Dynamics of σ-1 Receptors (σ1 Binding Sites) in NG108-15 Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.
[78] L. Suva,et al. Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. , 1999, Bone.
[79] S. Said,et al. Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[80] G. Wilcox,et al. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. , 1987, The Journal of pharmacology and experimental therapeutics.
[81] D. Johnson,et al. Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O-sulfamate. , 1995, Brain research. Cognitive brain research.
[82] J. E. Huettner,et al. Activation and Desensitization of Hippocampal Kainate Receptors , 1997, The Journal of Neuroscience.
[83] J. Collins,et al. Molecular and Functional Analysis of a Novel Neuronal Vesicular Glutamate Transporter* , 2001, The Journal of Biological Chemistry.
[84] X. Navarro,et al. Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice , 2012, Neurotherapeutics.
[85] A. M. Myers,et al. Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor. , 1994, Journal of medicinal chemistry.
[86] Thorsten Trapp,et al. Neurosteroids: Molecular mechanisms of action and psychopharmacological significance , 1996, The Journal of Steroid Biochemistry and Molecular Biology.
[87] E. Hinoi,et al. Modulation of cellular differentiation by N‐methyl‐d‐aspartate receptors in osteoblasts , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[88] R. Quirion,et al. [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: Autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes , 1997, Neuroscience.
[89] P. Zheng,et al. Sigma-1 receptors amplify dopamine D1 receptor signaling at presynaptic sites in the prelimbic cortex. , 2010, Biochimica et biophysica acta.
[90] S. Paul,et al. Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: structure-activity studies. , 1994, The Journal of pharmacology and experimental therapeutics.
[91] K. Matsuno,et al. SA4503, a novel cognitive enhancer, with sigma 1 receptor agonistic properties. , 1997, Behavioural brain research.
[92] R. Baker,et al. L-glutamate-induced changes in intracellular calcium oscillation frequency through non-classical glutamate receptor binding in cultured rat myocardial cells. , 1995, Life sciences.
[93] Weimin Hong,et al. Evidence that the σ1 receptor is not directly coupled to G proteins , 2000 .
[94] Alastair M. Hosie,et al. Replacement of asparagine with arginine at the extracellular end of the second transmembrane (M2) region of insect GABA receptors increases sensitivity to penicillin G , 2006, Invertebrate Neuroscience.
[95] S. Paul,et al. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. , 1986, Science.
[96] L. Werling,et al. Regulation of [3H]dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptors , 1996, Schizophrenia Research.
[97] Teruo Hayashi,et al. The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse. , 2005, Life sciences.
[98] W. Wonderlin,et al. Inhibition of ATP‐sensitive potassium channels causes reversible cell‐cycle arrest of human breast cancer cells in tissue culture , 1995, Journal of cellular physiology.
[99] Shu-zheng Liu. Nonlinear Dose-Response Relationship in the Immune System following Exposure to Ionizing Radiation: Mechanisms and Implications , 2003, Nonlinearity in biology, toxicology, medicine.
[100] R. Quirion,et al. Expression of the purported sigma1 (σ1) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy , 2000, Journal of Chemical Neuroanatomy.
[101] H. Lara,et al. Glutamate and kainate effects on the noradrenergic neurons innervating the rat vas deferens , 1988, Journal of neuroscience research.
[102] R. Coggeshall,et al. Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery , 1998, The Journal of comparative neurology.
[103] S. Mellon,et al. Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[104] M. Molliver,et al. Organization of raphe-cortical projections in rat: A quantitative retrograde study , 1984, Brain Research Bulletin.
[105] M. Wu,et al. Modulation of volume-sensitive Cl - channels and cell volume by actin filaments and microtubules in human cervical cancer HT-3 cells. , 1999, Acta physiologica Scandinavica.
[106] C. Montigny,et al. Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: Single-cell studies in the rat , 2004, Psychopharmacology.
[107] J. Ohgane,et al. Nutritional regulation of gene expression of insulin-like growth factor-binding proteins and the acid-labile subunit in various tissues of rats. , 1996, The Journal of endocrinology.
[108] T. Nabeshima,et al. [The psychological stress model using motor suppression]. , 1999, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
[109] F. Gasparini,et al. Neuroprotective activity of metabotropic glutamate receptor ligands. , 2002, Advances in experimental medicine and biology.
[110] K. Gee,et al. Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-o1-20-one. , 1991, Brain research.
[111] Jau-Shyong Hong,et al. Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse. , 2007, European journal of pharmacology.
[112] J. Urenjak,et al. Altered glutamatergic transmission in neurological disorders: From high extracellular glutamate to excessive synaptic efficacy , 1997, Progress in Neurobiology.
[113] Trevor Sharp,et al. A review of central 5-HT receptors and their function , 1999, Neuropharmacology.
[114] R. Nicoll,et al. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. , 1987, The Journal of physiology.
[115] U. Welsch,et al. Localization of a putative progesterone membrane binding protein in porcine hepatocytes. , 1998, Cellular and molecular biology.
[116] W. Bowen,et al. Ibogaine and its congeners are σ2 receptor-selective ligands with moderate affinity , 1995 .
[117] M. Parmentier,et al. Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. , 1999, European journal of pharmacology.
[118] P. Genever,et al. Expression of a functional N-methyl-D-aspartate-type glutamate receptor by bone marrow megakaryocytes. , 1999, Blood.
[119] B. Kocsis,et al. Electrophysiological evidence for convergence of inputs from the medial prefrontal cortex and lateral habenula on single neurons in the dorsal raphe nucleus , 2003, The European journal of neuroscience.
[120] Sigma receptor regulation of norepinephrine release from rat hippocampal slices , 1995, Brain Research.
[121] T. Nabeshima,et al. Neurosteroids Ameliorate Conditioned Fear Stress: An Association with Sigma1 Receptors , 2000, Neuropsychopharmacology.
[122] F. Tortella,et al. σ receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures , 1995, Brain Research.
[123] R. Duman,et al. Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.
[124] G. Debonnel,et al. Distinct modulatory roles of sigma receptor subtypes on glutamatergic responses in the dorsal hippocampus , 2005, Synapse.
[125] M. Amar,et al. Structure and Pharmacological Properties of a Molluscan Glutamate-Gated Cation Channel and its Likely Role in Feeding Behavior , 1996, The Journal of Neuroscience.
[126] Baofeng Yang,et al. HERG K+ channel, a regulator of tumor cell apoptosis and proliferation. , 2002, Cancer research.
[127] M. Friebe,et al. [99mTc]oxotechnetium(V) complexes amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma. , 2001, Journal of medicinal chemistry.
[128] D. V. van Helden,et al. The sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells. , 1996, Biochemical and biophysical research communications.
[129] V. Grutta,et al. Lateral habenular influence on dorsal raphe neurons , 1996, Brain Research Bulletin.
[130] H. Kwan,et al. Activity of voltage-gated K+ channels is associated with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer. , 1999, Life sciences.
[131] I. Guillemain,et al. Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. , 2000, Neuroscience.
[132] P. Hurn,et al. Sigma 1 Receptor Agonists Act as Neuroprotective Drugs Through Inhibition of Inducible Nitric Oxide Synthase , 2006, Anesthesia and analgesia.
[133] P. D. H. Schulz. Zur Lehre von der Arzneiwirkung , 1887, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.
[134] R. Thisted,et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine , 2004, Neurology.
[135] G. F. Steinfels,et al. Interactions between U-50,488H and sigma receptor antagonists: EEG, EEG power spectral and behavioral correlates. , 1993, European journal of pharmacology.
[136] B. Gustafsson,et al. Ionotropic glutamate receptors. Their possible role in the expression of hippocampal synaptic plasticity. , 1996, Molecular neurobiology.
[137] M. Tubiana,et al. Dose-effect relationship and estimation of the carcinogenic effects of low doses of ionizing radiation: the joint report of the Académie des Sciences (Paris) and of the Académie Nationale de Médecine. , 2006, International journal of radiation oncology, biology, physics.
[138] S. Beck,et al. Imipramine alters β-adrenergic, but not serotonergic, mediated responses in rat hippocampal pyramidal cells , 1989, Brain Research.
[139] M. Scherz,et al. Sigma receptors regulate contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation elicited by both electrical stimulation and exogenous serotonin , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[140] J. Wakerley,et al. The neurosteroid pregnenolone sulphate enhances NMDA-induced phasic firing of vasopressin neurones in the rat supraoptic nucleus , 1997, Neuroscience Letters.
[141] A. Akaike,et al. Effect of SA4503, a novel sigma1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons. , 1998, European journal of pharmacology.
[142] A. Privat,et al. Preserved sigma1 (σ1) receptor expression and behavioral efficacy in the aged C57BL/6 mouse , 2003, Neurobiology of Aging.
[143] D. Naber,et al. Efficacy and Safety of an Opiate Sigma-Receptor Antagonist (SL 82.0715) in Schizophrenic Patients with Negative Symptoms: an Open Dose-Range Study , 1996, Pharmacopsychiatry.
[144] L. Wiklund,et al. Possible excitatory amino acid afferents to nucleus raphe dorsalis of the rat investigated with retrograde wheat germ agglutinin and d-[3H]aspartate tracing , 1985, Brain Research.
[145] S. Heinemann,et al. Cloning of a novel glutamate receptor subunit, GluR5: Expression in the nervous system during development , 1990, Neuron.
[146] J. Macher,et al. Dopaminergic function and the cortisol response to dexamethasone in psychotic depression , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[147] J. Schetz,et al. An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones. , 2008, European journal of pharmacology.
[148] J. Jeong,et al. Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors , 2012, Neurochemistry International.
[149] J. Olney. Glutamate, a Neurotoxic Transmitter , 1989, Journal of child neurology.
[150] B. Meldrum. Amino acids as dietary excitotoxins: A contribution to understanding neurodegenerative disorders , 1993, Brain Research Reviews.
[151] I. Paul,et al. Modulation of (+)-[3H]pentazocine binding to guinea pig cerebellum by divalent cations. , 1992, Molecular pharmacology.
[152] S. Lipton,et al. Calcium, free radicals and excitotoxins in neuronal apoptosis. , 1998, Cell calcium.
[153] Metabotropic glutamate receptor agonists stimulate polyphosphoinositide hydrolysis in primary cultures of rat hepatocytes. , 1997, European journal of pharmacology.
[154] W. Bowen,et al. Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells. , 2000, The Journal of pharmacology and experimental therapeutics.
[155] A. Schwab,et al. K+ Channel-Dependent Migration of Fibroblasts and Human Melanoma Cells , 1999, Cellular Physiology and Biochemistry.
[156] S. L. Patrick,et al. Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma receptor ligands. , 1993, European journal of pharmacology.
[157] K. R. Rodvelt,et al. Could sigma receptor ligands be a treatment for methamphetamine addiction? , 2010, Current Drug Abuse Reviews.
[158] C. Frye,et al. Neurosteroids Affect Spatial/Reference, Working, and Long-Term Memory of Female Rats , 1995, Neurobiology of Learning and Memory.
[159] J. Russell,et al. Metabotropic glutamate receptor regulation of neuronal cell death , 2003, Experimental Neurology.
[160] L. Cazin,et al. A-Current down-modulated by sigma receptor in frog pituitary melanotrope cells through a G protein-dependent pathway. , 1999, The Journal of pharmacology and experimental therapeutics.
[161] P. Wood,et al. Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo , 1990, Neuropharmacology.
[162] T. Hayashi,et al. A perspective on the new mechanism of antidepressants: neuritogenesis through sigma-1 receptors. , 2004, Pharmacopsychiatry.
[163] M. Weissman,et al. The validity of major depression with psychotic features based on a community study. , 1991, Archives of general psychiatry.
[164] L. Werling,et al. Sigma2 (σ2) receptors as a target for cocaine action in the rat striatum , 2006 .
[165] Teruo Hayashi,et al. σ-1 Receptors (σ1 Binding Sites) Form Raft-Like Microdomains and Target Lipid Droplets on the Endoplasmic Reticulum: Roles in Endoplasmic Reticulum Lipid Compartmentalization and Export , 2003, Journal of Pharmacology and Experimental Therapeutics.
[166] V. Gundersen,et al. A High Affinity Glutamate/Aspartate Transport System in Pancreatic Islets of Langerhans Modulates Glucose-stimulated Insulin Secretion* , 1998, The Journal of Biological Chemistry.
[167] Byeong Keun Ha,et al. Initial characterization and autoradiographic localization of a novel sigma/opioid binding site in immune tissues , 1996, Journal of Neuroimmunology.
[168] Y. Mei,et al. Sigma-1 Receptor Agonists Directly Inhibit NaV1.2/1.4 Channels , 2012, PloS one.
[169] J. Maloteaux,et al. Is the sigma 2 receptor in rat brain related to the K+ channel of class III antiarrhythmic drugs? , 1993, European journal of pharmacology.
[170] Abraham Weizman,et al. Anti-proliferative activity of haloperidol in B16 mouse and human SK-MEL-28 melanoma cell lines. , 2005, International Journal of Oncology.
[171] Megan Lerner,et al. σ Receptors: potential medications development target for anti-cocaine agents , 2003 .
[172] J. Benson,et al. Expression of mRNA for the N-methyl-d-aspartate (NMDAR1) receptor by the enteric neurons of the rat , 1994, Neuroscience Letters.
[173] Byeong Keun Ha,et al. Differential localization of three distinct binding sites for sigma receptor ligands in rat spleen , 1997, Journal of Neuroimmunology.
[174] S. Heinemann,et al. Molecular cloning and functional expression of glutamate receptor subunit genes. , 1990, Science.
[175] E. Aydar,et al. The expression and functional characterization of sigma (sigma) 1 receptors in breast cancer cell lines. , 2006, Cancer letters.
[176] H. Lester,et al. Cloning and expression of a rat brain GABA transporter. , 1990, Science.
[177] V. Ganapathy,et al. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. , 1997, Biochemical and biophysical research communications.
[178] B. McEwen,et al. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens , 1994, Brain Research Reviews.
[179] J. Awapara,et al. FREE γ-AMINOBUTYRIC ACID IN BRAIN , 1950 .
[180] G. Debonnel,et al. Effects of bilateral olfactory bulbectomy on N‐methyl‐D‐aspartate receptor function: Autoradiographic and behavioral studies in the rat , 2001, Synapse.
[181] Y. Itzhak,et al. Regulation of σ receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple σ binding sites , 1991, Brain Research.
[182] P. Seeburg,et al. Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. , 1989, Science.
[183] W. Bowen,et al. Rat liver and kidney contain high densities of σ1 and σ2 receptors: characterization by ligand binding and photoaffinity labeling , 1994 .
[184] J E Dowling,et al. On bipolar cell responses in the teleost retina are generated by two distinct mechanisms. , 1996, Journal of neurophysiology.
[185] K. Matsuno,et al. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. , 1993, The Journal of pharmacology and experimental therapeutics.
[186] H. Kwan,et al. Blockage of voltage-gated K+ channels inhibits adhesion and proliferation of hepatocarcinoma cells. , 2003, International journal of molecular medicine.
[187] R. Felder,et al. Expression of the subtype 1A dopamine receptor in the rat heart. , 1996, Hypertension.
[188] E. Chevet,et al. Sig1R Protein Regulates hERG Channel Expression through a Post-translational Mechanism in Leukemic Cells* , 2011, The Journal of Biological Chemistry.
[189] C. Altar,et al. Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523 , 2001, Neuropharmacology.
[190] L. Costa,et al. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes. , 1991, Immunopharmacology.
[191] J. Junien,et al. Neuropeptide Y and sigma ligand (JO 1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors. , 1992, The Journal of pharmacology and experimental therapeutics.
[192] Possible Involvement of a σ Receptor Subtype in the Neck Dystonia in Rats , 1999, Pharmacology Biochemistry and Behavior.
[193] P. Delmas,et al. Active NMDA glutamate receptors are expressed by mammalian osteoclasts , 1999, The Journal of physiology.
[194] D. Zamanillo,et al. Generation and phenotypic analysis of sigma receptor type I (σ1) knockout mice , 2003 .
[195] E. Calabrese. Nitric Oxide: Biphasic Dose Responses , 2001, Critical reviews in toxicology.
[196] F. R. Melo,et al. Mast cell apoptosis induced by siramesine, a sigma-2 receptor agonist. , 2012, Biochemical pharmacology.
[197] L. Combettes,et al. Protein Kinase C-Dependent Potentiation of Intracellular Calcium Influx by σ1 Receptor Agonists in Rat Hippocampal Neurons , 2003, Journal of Pharmacology and Experimental Therapeutics.
[198] E. Baulieu,et al. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[199] M. Erlander,et al. The structural and functional heterogeneity of glutamic acid decarboxylase: A review , 1991, Neurochemical Research.
[200] G. Halliday,et al. Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease. , 2011, Current Alzheimer research.
[201] A. Mahboubi,et al. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands. , 1991, Molecular pharmacology.
[202] N. M. Rao,et al. Haloperidol-associated Stealth Liposomes , 2005, Journal of Biological Chemistry.
[203] Teruo Hayashi,et al. Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells. , 2003, The Journal of pharmacology and experimental therapeutics.
[204] Rae R. Matsumoto,et al. Novel σ receptor ligands attenuate the locomotor stimulatory effects of cocaine , 1999 .
[205] R. Axel,et al. A family of glutamate receptor genes: Evidence for the formation of heteromultimeric receptors with distinct channel properties , 1990, Neuron.
[206] R. Berridge,et al. Contribution of functional voltage‐gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. lateral motility , 2003, Journal of cellular physiology.
[207] W. Bowen,et al. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors. , 1999, Cancer research.
[208] J. Siuciak,et al. Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF) , 1997, Pharmacology Biochemistry and Behavior.
[209] K. Hashimoto,et al. The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases , 2009 .
[210] E. London,et al. Pharmacological Characteristics and Distributions of σ and Phencyclidine Receptors in the Animal Kingdom , 1990, Journal of neurochemistry.
[211] Nidhi Kaushal,et al. Role of Sigma Receptors in Methamphetamine-Induced Neurotoxicity , 2011, Current neuropharmacology.
[212] T. Su,et al. The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. , 2001, The Journal of pharmacology and experimental therapeutics.
[213] K. Ossowska,et al. Role of metabotropic glutamate receptors in animal models of Parkinson's disease. , 2003, Polish journal of pharmacology.
[214] E. Laurini,et al. Another brick in the wall. Validation of the σ1 receptor 3D model by computer-assisted design, synthesis, and activity of new σ1 ligands. , 2012, Molecular pharmaceutics.
[215] J. Junien,et al. Reversal of CRF‐ and dopamine‐induced stimulation of colonic motility by CCK and igmesine (JO 1784) in the rat , 1994, British journal of pharmacology.
[216] Teruo Hayashi,et al. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. , 2004, CNS drugs.
[217] P. B. Gold,et al. Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder , 1998, Psychiatry Research.
[218] V. Ganapathy,et al. Cloning and Functional Characterization of a σ Receptor from Rat Brain , 1998 .
[219] M. Barrot,et al. The neurosteroid pregnenolone sulphate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens , 1999, The European journal of neuroscience.
[220] K. Ishiwata,et al. Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing rats , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[221] M. Hiramatsu,et al. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice , 2005, Behavioural Brain Research.
[222] Edward J Calabrese,et al. Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[223] T. Su,et al. Steroid binding at sigma receptors: CNS and immunological implications. , 1990, Ciba Foundation symposium.
[224] G. Skuza,et al. Antidepressant-like effect of PRE-084, a selective σ_1 receptor agonist, in Albino Swiss and C57BL/6J mice , 2009 .
[225] D. Rossi,et al. Sigma receptor modulators: a patent review , 2013, Expert opinion on therapeutic patents.
[226] B. Bayer,et al. In vivo effects of cocaine on immune cell function , 1998, Journal of Neuroimmunology.
[227] V. Neubauer,et al. Neuroprotective effects of the sigma-1 receptor ligand PRE-084 against excitotoxic perinatal brain injury in newborn mice , 2012, Experimental Neurology.
[228] P. Genever,et al. The NMDA Type Glutamate Receptors Expressed by Primary Rat Osteoblasts Have the Same Electrophysiological Characteristics as Neuronal Receptors , 2002, Calcified Tissue International.
[229] R. Coggeshall,et al. Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin , 1995, Neuroscience Letters.
[230] D. Farb,et al. 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. , 1994, Molecular pharmacology.
[231] T. Ishihara,et al. Repetitive questioning behavior in Alzheimer's disease: Relationship to regional cerebral blood flow , 2010, Psychiatry Research: Neuroimaging.
[232] G. Koob,et al. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. , 1997, European journal of pharmacology.
[233] R. Bon,et al. Inhibition of endothelial cell Ca2+ entry and transient receptor potential channels by Sigma-1 receptor ligands , 2013, British journal of pharmacology.
[234] D. Zamanillo,et al. A Medicinal‐Chemistry‐Guided Approach to Selective and Druglike Sigma 1 Ligands , 2006, ChemMedChem.
[235] W. Wonderlin,et al. Potassium Channels, Proliferation and G1 Progression , 1996, The Journal of Membrane Biology.
[236] Y. Itzhak,et al. Sigma binding sites in the brain; an emerging concept for multiple sites and their relevance for psychiatric disorders. , 1990, Life sciences.
[237] R. Oswald,et al. Emerging structural explanations of ionotropic glutamate receptor function , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[238] R. Hotchkiss,et al. Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site , 2011, Nature communications.
[239] S. Mellon,et al. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[240] G. Massicotte,et al. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. , 2004, European journal of pharmacology.
[241] J. Davison,et al. Review article: endocannabinoids and their receptors in the enteric nervous system , 2005, Alimentary pharmacology & therapeutics.
[242] V. Ganapathy,et al. Cloning and functional characterization of a sigma receptor from rat brain. , 1998, Journal of neurochemistry.
[243] K. Fukunaga,et al. Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice , 2013, PloS one.
[244] P. Casellas,et al. Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. , 2001, Biochimica et biophysica acta.
[245] V. Young,et al. Glutamate: an amino acid of particular distinction. , 2000, The Journal of nutrition.
[246] J. Kulikowski,et al. Are the amplitudes of visual evoked potentials sensitive indices of hangover effects after repeated doses of benzodiazepines? , 1984, Psychopharmacology. Supplementum.
[247] C. Montigny,et al. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. , 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[248] D. Schoepp,et al. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage , 1992, Neuroscience Letters.
[249] O. Pulido,et al. The Monkey (Macaca fascicularis) Heart Neural Structures and Conducting System: An Immunochemical Study of Selected Neural Biomarkers and Glutamate Receptors , 2003, Toxicologic pathology.
[250] V. Ganapathy,et al. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). , 1996, Biochemical and biophysical research communications.
[251] W. Abraham,et al. Flip side of synaptic plasticity: Long‐term depression mechanisms in the hippocampus , 1994, Hippocampus.
[252] R. Yoshimura,et al. Risperidone in the treatment of psychotic depression , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[253] S. Lipton,et al. Excitotoxins in Neuronal Apoptosis and Necrosis , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[254] W. Purcell,et al. Characterisation of a functional polyamine site on rat mast cells: association with a NMDA receptor macrocomplex , 1996, Journal of Neuroimmunology.
[255] J. Olney. Excitotoxins in foods. , 1994, Neurotoxicology.
[256] M. Bear,et al. Experience-dependent modification of synaptic plasticity in visual cortex , 1996, Nature.
[257] Kjell Erlandsson,et al. [123I]TPCNE—A novel SPET tracer for the sigma‐1 receptor: First human studies and in vivo haloperidol challenge , 2006, Synapse.
[258] P. Dunkley,et al. Protein Phosphorylation and Calcium Uptake into Rat Forebrain Synaptosomes: Modulation by the σ Ligand, 1,3‐Ditolylguanidine , 1997, Journal of neurochemistry.
[259] Matthias J. Müller,et al. Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial , 1999, Psychiatry Research.
[260] E. Harris,et al. sigma2 Site-mediated inhibition of electrically evoked guinea pig ileum longitudinal muscle/myenteric plexus contractions. , 1995, European journal of pharmacology.
[261] V. Ganapathy,et al. Electrogenic nature of rat sodium-dependent multivitamin transport. , 2000, Biochemical and biophysical research communications.
[262] P. Seeburg,et al. Molecular biology of the GABAA receptor. , 1988, Advances in experimental medicine and biology.
[263] Hong-wei Dong,et al. Activation of Group I Metabotropic Glutamate Receptors on Main Olfactory Bulb Granule Cells and Periglomerular Cells Enhances Synaptic Inhibition of Mitral Cells , 2007, The Journal of Neuroscience.
[264] D. W. Parish,et al. Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. , 1991, The Journal of pharmacology and experimental therapeutics.
[265] D. Manallack,et al. Regulation of σ‐Receptors: High‐ and Low‐Affinity Agonist States, GTP Shifts, and Up‐Regulation by Rimcazole and 1,3‐Di(2‐Tolyl)guanidine , 1989, Journal of neurochemistry.
[266] O. Pulido,et al. Neuroexcitatory Targets in the Female Reproductive System of the Nonhuman Primate (Macaca fascicularis) , 2008, Toxicologic pathology.
[267] E. Molnár,et al. Identification of functional ionotropic glutamate receptor proteins in pancreatic β‐cells and in islets of Langerhans , 1995, FEBS letters.
[268] Stein Gf,et al. Selective σ receptor agonist and antagonist affect dopamine neuronal activity , 1989 .
[269] D. G. Lindsay. Nutrition, hormetic stress and health , 2005, Nutrition Research Reviews.
[270] J. Hedreen,et al. Sigma receptors in post-mortem human brains. , 1988, The Journal of pharmacology and experimental therapeutics.
[271] M. Le Moal,et al. Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[272] S. Arnold,et al. Elevated progesterone receptor membrane component 1/sigma‐2 receptor levels in lung tumors and plasma from lung cancer patients , 2012, International journal of cancer.
[273] A R Stebbing. Hormesis: interpreting the beta-curve using control theory. , 2000, Journal of applied toxicology : JAT.
[274] R. Khokha,et al. Molecular mechanisms of tumor invasion and metastasis: an integrated view. , 2003, Current molecular medicine.
[275] P. Seeburg,et al. Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology , 1989, Nature.
[276] Teruo Hayashi,et al. Nerve Growth Factor-Induced Neurite Sprouting in PC12 Cells Involves ς-1 Receptors: Implications for Antidepressants , 2002, Journal of Pharmacology and Experimental Therapeutics.
[277] Dehydroepiandrosterone (DHEA) treatment of depression , 1997, Biological Psychiatry.
[278] J. Seagard,et al. Role of glutamate receptors in transmission of vagal cardiac input to neurones in the nucleus tractus solitarii in dogs , 1999, The Journal of physiology.
[279] J. Baeyens,et al. &sgr;1 Receptors Are Involved in the Visceral Pain Induced by Intracolonic Administration of Capsaicin in Mice , 2013, Anesthesiology.
[280] E. Portales-Casamar,et al. The antidepressant-like effect induced by the sigma1 (σ1) receptor agonist igmesine involves modulation of intracellular calcium mobilization , 2002, Psychopharmacology.
[281] J. A. Peters,et al. Modulation of the GABAA receptor by progesterone metabolites , 1987, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[282] R. Mach,et al. Sigma-2 receptors as a biomarker of proliferation in solid tumours , 2000, British Journal of Cancer.
[283] G. Pasternak,et al. σ1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding , 2010, Molecular Pharmacology.
[284] S. Tam. Naloxone-inaccessible sigma receptor in rat central nervous system. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[285] Thomas Knöpfel,et al. Book Review: Metabotropic Glutamate Receptors: Electrical and Chemical Signaling Properties , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[286] H. Manji,et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression , 2003, Biological Psychiatry.
[287] T. Moody,et al. Increased binding to sigma sites of N-[1'(2-piperidinyl)ethyl)-4-[I-125]-iodobenzamide (I-125-PAB) with onset of tumor cell proliferation. , 1998, Life sciences.
[288] M. Hajós,et al. In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptors , 2003, Neuropharmacology.
[289] S. Lipton,et al. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. , 1995, The New England journal of medicine.
[290] A. Privat,et al. Modulation by neurosteroids of the in vivo (+)‐[3H]SKF‐10,047 binding to σ1 receptors in the mouse forebrain , 1996, Journal of neuroscience research.
[291] T. C. Bond,et al. The DST in psychotic depression: diagnostic and pathophysiologic implications. , 1984, Psychopharmacology bulletin.
[292] W. Bowen,et al. Highly selective σ receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes , 1998 .
[293] T. Kameyama,et al. Effects of apomorphine and diazepam on a quickly learned conditioned suppression in rats , 1982, Pharmacology Biochemistry and Behavior.
[294] J. Cuevas,et al. σ Receptor Activation Blocks Potassium Channels and Depresses Neuroexcitability in Rat Intracardiac Neurons , 2005, Journal of Pharmacology and Experimental Therapeutics.
[295] K. Hashimoto,et al. Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors , 2009, Annals of general psychiatry.
[296] F. Chisari,et al. Sigma-1 Receptor Regulates Early Steps of Viral RNA Replication at the Onset of Hepatitis C Virus Infection , 2013, Journal of Virology.
[297] M. Kavanaugh,et al. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel , 1995, Nature.
[298] J. Bockaert,et al. Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. , 1993, European journal of pharmacology.
[299] B. Testa,et al. [3H]‐Trimetazidine mitochondrial binding sites: regulation by cations, effect of trimetazidine derivatives and other agents and interaction with an endogenous substance , 2000, British journal of pharmacology.
[300] T. Moody,et al. Sigma ligands inhibit the growth of small cell lung cancer cells. , 2000, Life sciences.
[301] W. Bowen,et al. Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes. , 2004, European journal of pharmacology.
[302] W. Bowen. Sigma receptors: recent advances and new clinical potentials. , 2000, Pharmaceutica acta Helvetiae.
[303] E. Detrait,et al. Inhibitory effects of sigma‐1 ligands on handling‐induced tachycardia in conscious tethered rats , 2013, Fundamental & clinical pharmacology.
[304] C. Altar,et al. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate). , 2002, The Journal of pharmacology and experimental therapeutics.
[305] Teruo Hayashi,et al. When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor , 2009, Science Signaling.
[306] Robert F. Miller,et al. NBQX, an improved non-NMDA antagonist studied in retinal ganglion cells , 1995, Brain Research.
[307] B. Costall,et al. The selective sigma2-ligand Lu 28-179 has potent anxiolytic-like effects in rodents. , 1997, Journal of Pharmacology and Experimental Therapeutics.
[308] G. Kaur,et al. Prolonged glutamate excitotoxicity: Effects on mitochondrial antioxidants and antioxidant enzymes , 2004, Molecular and Cellular Biochemistry.
[309] William K. Stell,et al. Immunocytochemical localization of the high-affinity glutamate transporter, EAAC1, in the retina of representative vertebrate species , 1996, Neuroscience Letters.
[310] P. Seeburg. The TINS/TiPS Lecture the molecular biology of mammalian glutamate receptor channels , 1993, Trends in Neurosciences.
[311] S. Nakanishi,et al. Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca2+ signal transduction. , 1992, The Journal of biological chemistry.
[312] M. Farthing. Novel agents for the control of secretory diarrhoea , 2004, Expert opinion on investigational drugs.
[313] E. Calabrese. Dopamine: Biphasic Dose Responses , 2001, Critical reviews in toxicology.
[314] E. London,et al. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. , 1988, Science.
[315] T. Su,et al. Sigma receptors. Putative links between nervous, endocrine and immune systems. , 1991, European journal of biochemistry.
[316] W. Wonderlin,et al. An ATP-Sensitive K+ Current that Regulates Progression Through Early G1 Phase of the Cell Cycle in MCF-7 Human Breast Cancer Cells , 1999, The Journal of Membrane Biology.
[317] T. Verdoorn,et al. Differential Expression of Glutamate Receptor Subtypes in Rat Pancreatic Islets* , 1996, The Journal of Biological Chemistry.
[318] B. Jarrott,et al. Sigma-1 receptor ligand PRE-084 reduced infarct volume, neurological deficits, pro-inflammatory cytokines and enhanced anti-inflammatory cytokines after embolic stroke in rats , 2011, Brain Research Bulletin.
[319] P. Romieu,et al. σ1 Receptor Ligands and Related Neuroactive Steroids Interfere with the Cocaine-Induced State of Memory , 2006, Neuropsychopharmacology.
[320] L. Monassier,et al. Sigma receptors: from discovery to highlights of their implications in the cardiovascular system , 2002, Fundamental & clinical pharmacology.
[321] V. Ganapathy,et al. Sigma receptor 1 modulates endoplasmic reticulum stress in retinal neurons. , 2011, Investigative ophthalmology & visual science.
[322] S. Goldberg,et al. Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls , 2004, Psychopharmacology.
[323] Christian Ritz,et al. Improved empirical models describing hormesis , 2005, Environmental toxicology and chemistry.
[324] J. Morley,et al. Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[325] R. Walker. The significance of excursions above the ADI. Case study: monosodium glutamate. , 1999, Regulatory toxicology and pharmacology : RTP.
[326] M. Beal,et al. Excitotoxicity and nitric oxide in parkinson's disease pathogenesis , 1998, Annals of neurology.
[327] W. Bem,et al. Sigma and opioid receptors in human brain tumors. , 1990, Life sciences.
[328] D. Attwell,et al. Electrogenic glutamate uptake is a major current carrier in the membrane of axolotl retinal glial cells , 1987, Nature.
[329] Y Itzhak,et al. Multiple affinity binding states of the sigma receptor: effect of GTP-binding protein-modifying agents. , 1989, Molecular pharmacology.
[330] K. Nakasho,et al. Relationship between Sigma‐like site and progesterone‐binding site of adult male rat liver microsomes , 1994, Hepatology.
[331] M. Hajós,et al. Evidence for a role of GABA interneurones in the cortical modulation of midbrain 5-hydroxytryptamine neurones , 2001, Neuroscience.
[332] F. Nyberg,et al. Chronic administration of the anabolic androgenic steroid nandrolone alters neurosteroid action at the sigma-1 receptor but not at the sigma-2 or NMDA receptors , 2011, Neuropharmacology.
[333] I. Izquierdo,et al. Pharmacological evidence for a role of long-term potentiation in memory. , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[334] M. Fresno,et al. Inhibitory Effects of Sigma-2 Receptor Agonists on T Lymphocyte Activation , 2013, Front. Pharmacol..
[335] K. Matsuno,et al. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. , 1996, European journal of pharmacology.
[336] Z. Janka,et al. Association between a variant of the sigma-1 receptor gene and Alzheimer's disease , 2012, Neuroscience Letters.
[337] O. Pulido,et al. Human Heart Glutamate Receptors—Implications for Toxicology, Food Safety, and Drug Discovery , 2007, Toxicologic pathology.
[338] S. Rattan. Aging intervention, prevention, and therapy through hormesis. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.
[339] W. Bowen,et al. Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. , 1995, European journal of pharmacology.
[340] A. Serretti,et al. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. , 2000, The Journal of clinical psychiatry.
[341] E. Wolters,et al. Management of non-motor symptoms in advanced Parkinson disease , 2008, Journal of the Neurological Sciences.
[342] C. Foster,et al. Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells , 1998, FEBS letters.
[343] G. Aghajanian,et al. Serotonergic and non-serotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation , 1978, Brain Research.
[344] W. Bowen,et al. Sigma receptors: biology and function. , 1990, Pharmacological reviews.
[345] E. Calabrese,et al. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. , 2005, Toxicology and applied pharmacology.
[346] R. Toyoshima,et al. Lack of G protein-coupled sigma receptors in rat brain membranes: receptor-mediated high-affinity GTPase activity and [35S]GTPγS binding studies , 2005, Journal of Neural Transmission.
[347] S. Schwarz,et al. Steroid binding at sigma-"opioid" receptors. , 1989, Science.
[348] E. Roberts. Pregneolone--from Selye to Alzheimer and a model of the pregnenolone sulfate binding site on the GABAA receptor. , 1995, Biochemical pharmacology.
[349] Teruo Hayashi,et al. Compromising σ-1 Receptors at the Endoplasmic Reticulum Render Cytotoxicity to Physiologically Relevant Concentrations of Dopamine in a Nuclear Factor-κB/Bcl-2-Dependent Mechanism: Potential Relevance to Parkinson's Disease , 2012, Journal of Pharmacology and Experimental Therapeutics.
[350] P. Romieu,et al. Involvement of the Sigma1 Receptor in Cocaine-induced Conditioned Place Preference: Possible Dependence on Dopamine Uptake Blockade , 2002, Neuropsychopharmacology.
[351] F. Sarlak,et al. Pregnenolone sulfate increases intracellular Ca2+ levels in a pituitary cell line. , 1996, European journal of pharmacology.
[352] J. ffrench-Mullen,et al. Neurosteroids block Ca2+ channel current in freshly isolated hippocampal CA1 neurons. , 1991, European journal of pharmacology.
[353] E. J. Fletcher,et al. Blockade by sigma site ligands of high voltage‐activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurones , 1995, British journal of pharmacology.
[354] D. Zamanillo,et al. Immunohistochemical localization of the sigma1-receptor in oligodendrocytes in the rat central nervous system. , 2003, Brain research.
[355] S. Heinemann,et al. Kainate Receptors Are Involved in Short- and Long-Term Plasticity at Mossy Fiber Synapses in the Hippocampus , 2001, Neuron.
[356] A. Privat,et al. Modulation of steroidal levels by adrenalectomy/castration and inhibition of neurosteroid synthesis enzymes affect σ1 receptor‐mediated behaviour in mice , 1999, The European journal of neuroscience.
[357] T. Iwanaga,et al. Expression and role of ionotropic glutamate receptors in pancreatic islet cells , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[358] Jiajia Wang,et al. Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice. , 2007, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.
[359] E J Calabrese,et al. Hormesis: U-shaped dose responses and their centrality in toxicology. , 2001, Trends in pharmacological sciences.
[360] S. Naito,et al. Adenosine triphosphate-dependent uptake of glutamate into protein I-associated synaptic vesicles. , 1983, The Journal of biological chemistry.
[361] K. Mackie,et al. Distribution of cannabinoid receptors in the central and peripheral nervous system. , 2005, Handbook of experimental pharmacology.
[362] T. Su,et al. Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (sigma sites) exhibit a unique distribution in rat brain subcellular fractions. , 1990, European journal of pharmacology.
[363] L. Tsao,et al. Naloxone‐sensitive, haloperidol‐sensitive, [3H] (+) SKF‐10047‐binding protein partially purified from rat liver and rat brain membranes: An opioid/sigma receptor? , 1997, Synapse.
[364] S. Konitsiotis. Novel pharmacological strategies for motor complications in Parkinson’s disease , 2005, Expert opinion on investigational drugs.
[365] E. Calabrese. Amyloid beta-peptide: biphasic dose responses. , 2001, Critical reviews in toxicology.
[366] G Tocco,et al. Postsynaptic factors in the expression of long-term potentiation (LTP): increased glutamate receptor binding following LTP induction in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[367] P. Stanton,et al. Long-term potentiation and N-methyl-d-aspartate receptors: Foundations of memory and neurologic disease? , 1995, Neuroscience & Biobehavioral Reviews.
[368] C. Decaestecker,et al. Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy , 2012, Medicinal research reviews.
[369] M. Thase,et al. Emerging drugs for major depressive disorder , 2012, Expert opinion on emerging drugs.
[370] G. Debonnel,et al. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. , 1990, European journal of pharmacology.
[371] G. Skuza. Pharmacology of sigma (σ) receptor ligands from a behavioral perspective. , 2012, Current pharmaceutical design.
[372] L. Tsai. Function of GABAergic and glutamatergic neurons in the stomach. , 2005, Journal of biomedical science.
[373] P. Seeburg,et al. Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family , 1987, Nature.
[374] J. Musacchio,et al. High affinity dextromethorphan binding sites in guinea pig brain: further characterization and allosteric interactions. , 1988, The Journal of pharmacology and experimental therapeutics.
[375] T. Tsumoto,et al. Postsynaptic calcium and calcium-dependent processes in synaptic plasticity in the developing visual cortex , 1996, Journal of Physiology-Paris.
[376] T. Nabeshima,et al. Sigma receptor ligands (+)-SKF10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats. , 1998, European journal of pharmacology.
[377] E. Rojas,et al. Sigma receptors modulate nicotinic receptor function in adrenal chromaffin cells , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[378] L. Combettes,et al. Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons. , 2003, The Journal of pharmacology and experimental therapeutics.
[379] W. Bowen,et al. Synthesis and evaluation of optically pure [3H]‐(+)‐pentazocine, a highly potent and selective radioligand for σ receptors , 1989 .
[380] Q. Pittman,et al. Cannabinoid CB2 Receptors in Health and Disease , 2010 .
[381] A. Schatzberg. New approaches to managing psychotic depression. , 2003, The Journal of clinical psychiatry.
[382] S. Nakanishi. Molecular diversity of glutamate receptors and implications for brain function. , 1992, Science.
[383] C. Rousseaux. A Review of Glutamate Receptors I : Current Understanding of Their Biology , 2008 .
[384] K. Hashimoto,et al. Cognition and depression: the effects of fluvoxamine, a sigma‐1 receptor agonist, reconsidered , 2010, Human psychopharmacology.
[385] M. E. Gulden,et al. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors. , 1998, Nuclear medicine and biology.
[386] R. Hirschfeld. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. , 1999, The Journal of clinical psychiatry.
[387] J H Connick,et al. Multiple sigma binding sites in guinea-pig and rat brain membranes: G-protein interactions. , 1992, British journal of pharmacology.
[388] Jiajia Wang,et al. Novel sigma (σ) receptor agonists produce antidepressant-like effects in mice , 2007, European Neuropsychopharmacology.
[389] A. Colino,et al. Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin , 1987, Nature.
[390] T. Zetterström,et al. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. , 1998, Brain research. Molecular brain research.
[391] F. Monnet. Sigma‐1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance , 2005, Biology of the cell.
[392] C F Stevens,et al. The tetrameric structure of a glutamate receptor channel. , 1998, Science.
[393] G. Debonnel,et al. Gender and gonadal status modulation of dorsal raphe nucleus serotonergic neurons. Part II. Regulatory mechanisms , 2002, Neuropharmacology.
[394] H. Yamada,et al. Secretory Granule-mediated Co-secretion ofl-Glutamate and Glucagon Triggers Glutamatergic Signal Transmission in Islets of Langerhans* , 2003, The Journal of Biological Chemistry.
[395] T. Maurice. Neurosteroids and σ1 Receptors, Biochemical and Behavioral Relevance , 2004, Pharmacopsychiatry.
[396] I. Najm,et al. Altered Glutamate Receptor—Transporter Expression and Spontaneous Seizures in Rats Exposed to Methylazoxymethanol in Utero , 2007, Epilepsia.
[397] S. Nakanishi,et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor , 2000, Nature.
[398] T. Kameyama,et al. Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia , 1994, Brain Research.
[399] M. Mayer,et al. Permeation and block of N‐methyl‐D‐aspartic acid receptor channels by divalent cations in mouse cultured central neurones. , 1987, The Journal of physiology.
[400] M Tohyama,et al. Characteristic localization of non-NMDA type glutamate receptor subunits in the rat pituitary gland. , 1993, Brain research. Molecular brain research.
[401] C. Iadecola. Bright and dark sides of nitric oxide in ischemic brain injury , 1997, Trends in Neurosciences.
[402] J. Poupaert,et al. Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity. , 2008, Journal of medicinal chemistry.
[403] B. Bode. Recent molecular advances in mammalian glutamine transport. , 2001, The Journal of nutrition.
[404] Deepani Jinadasa,et al. Slow Actions of Neuroactive Steroids at GABAA Receptors , 2004, The Journal of Neuroscience.
[405] P. Lindström,et al. Effect of N-methyl-D,L-aspartate on isolated rat somatotrophs. , 1992, Endocrinology.
[406] T. Dierks,et al. EEG and auditory evoked potential P300 compared with psychometric tests in assessing vigilance after benzodiazepine sedation and antagonism. , 1992, British journal of anaesthesia.
[407] Dennis K. Miller,et al. Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418 , 2014, The Journal of Pharmacology and Experimental Therapeutics.
[408] J. Nishikawa,et al. Molecular cloning and functional characterization of a novel nuclear receptor similar to an embryonic benzoate receptor BXR. , 2000, Biochemical and biophysical research communications.
[409] D. Standaert,et al. Rationale for and use of NMDA receptor antagonists in Parkinson's disease. , 2004, Pharmacology & therapeutics.
[410] G. Shama,et al. UV hormesis in fruits: a concept ripe for commercialisation , 2005 .
[411] Samira G. Ferreira,et al. Presynaptic CB1 cannabinoid receptors control frontocortical serotonin and glutamate release – Species differences , 2012, Neurochemistry International.
[412] B. Bunney,et al. The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. , 1984, European journal of pharmacology.
[413] G. Debonnel,et al. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. , 1999, European journal of pharmacology.
[414] L. Cazin,et al. Electrophysiological effects of various neuroactive steroids on the GABA(A) receptor in pituitary melanotrope cells. , 1997, European journal of pharmacology.
[415] E. Aydar,et al. Sigma Receptors and Cancer , 2004, Cancer Research.
[416] R. Mach,et al. Sigma 2 receptors as potential biomarkers of proliferation in breast cancer. , 1997, Cancer research.
[417] G. Hortobagyi,et al. Expression of sigma 1 receptor in human breast cancer , 2004, Breast Cancer Research and Treatment.
[418] H. Bose,et al. σ-1 Receptor at the Mitochondrial-Associated Endoplasmic Reticulum Membrane Is Responsible for Mitochondrial Metabolic Regulation , 2012, Journal of Pharmacology and Experimental Therapeutics.
[419] T. Branchek,et al. Molecular heterogeneity of the gamma-aminobutyric acid (GABA) transport system. Cloning of two novel high affinity GABA transporters from rat brain. , 1992, The Journal of biological chemistry.
[420] D. Zamanillo,et al. Up-regulation of sigma1 receptor mRNA in rat brain by a putative atypical antipsychotic and sigma receptor ligand , 2000, Neuroscience Letters.
[421] S. Enna,et al. Excitatory amino acid receptors: a gallery of new targets for pharmacological intervention. , 1994, Life sciences.
[422] Edward J. Calabrese,et al. The Importance of Hormesis to Public Health , 2006, Environmental health perspectives.
[423] K. Belbin,et al. Examination of four 123I-labeled piperidine-based sigma receptor ligands as potential melanoma imaging agents: initial studies in mouse tumor models. , 1997, Nuclear medicine and biology.
[424] P. Krogsgaard‐Larsen,et al. Naturally-occurring excitatory amino acids as neurotoxins and leads in drug design. , 1992, Toxicology letters.
[425] R. Mach,et al. SV119-gold nanocage conjugates: a new platform for targeting cancer cells via sigma-2 receptors. , 2012, Nanoscale.
[426] J. Flood,et al. Dehydroepiandrosterone sulfate improves memory in aging mice , 1988, Brain Research.
[427] Ling Chen,et al. Anti-amnesic effect of neurosteroid PREGS in Aβ25–35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection , 2012, Neuropharmacology.
[428] H. Ujike,et al. sigma Receptor antagonists block the development of sensitization to cocaine. , 1996, European journal of pharmacology.
[429] G. Debonnel,et al. The role of sigma receptors in depression. , 2005, Journal of pharmacological sciences.
[430] A. Kaneko,et al. L-glutamate-induced depolarization in solitary photoreceptors: a process that may contribute to the interaction between photoreceptors in situ. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[431] S. Paul,et al. The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task , 1994, Psychopharmacology.
[432] L. Monassier,et al. σ2-Receptor Ligand-Mediated Inhibition of Inwardly Rectifying K+ Channels in the Heart , 2007, Journal of Pharmacology and Experimental Therapeutics.
[433] J. Olney,et al. Acute elevations of serum luteinizing hormone induced by kainic acid, N-methyl aspartic acid or homocysteic acid. , 1978, Neuroendocrinology.
[434] De-Pei Li,et al. Differential roles for glutamate receptor subtypes within commissural NTS in cardiac-sympathetic reflex. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[435] C. Cotman,et al. Roles of Metabotropic Glutamate Receptors in Brain Plasticity and Pathology , 1995, Annals of the New York Academy of Sciences.
[436] H. Lecar,et al. Glutamate-gated chloride channel with glutamate-transporter-like properties in cone photoreceptors of the tiger salamander. , 1995, Journal of neurophysiology.
[437] N. Danbolt. Glutamate uptake , 2001, Progress in Neurobiology.
[438] J. D. McGaugh,et al. Interaction of GABAergic and beta-noradrenergic drugs in the regulation of memory storage. , 1994, Behavioral and neural biology.
[439] F. Berardi,et al. Arylamides hybrids of two high-affinity σ2 receptor ligands as tools for the development of PET radiotracers. , 2011, European journal of medicinal chemistry.
[440] J. Mogil,et al. 1,3-di-o-Tolylguanidine (DTG) differentially affects acute and tonic formalin pain: Antagonism by rimcazole , 1995, Pharmacology Biochemistry and Behavior.
[441] Steven W. Johnson,et al. The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism , 2009, Psychopharmacology.
[442] T. Wieloch,et al. Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. , 2014, Brain : a journal of neurology.
[443] F. Al-Mohanna,et al. A mutation in sigma‐1 receptor causes juvenile amyotrophic lateral sclerosis , 2011, Annals of neurology.
[444] E. Ikonen,et al. Functional rafts in cell membranes , 1997, Nature.
[445] Tetsuya Kobayashi,et al. Involvement of σ1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats , 1995, Brain Research.
[446] P. Daley,et al. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter , 2009, Journal of Neural Transmission.
[447] M. Jackson,et al. The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator , 2009, Science.
[448] M. Schumacher,et al. Steroid synthesis and metabolism in the nervous system: Trophic and protective effects , 2000, Journal of neurocytology.
[449] D. Burt,et al. GABAA receptor subtypes: from pharmacology to molecular biology , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[450] R. Matsumoto,et al. Involvement of sigma (σ) receptors in the acute actions of methamphetamine: Receptor binding and behavioral studies , 2005, Neuropharmacology.
[451] G. Gudelsky. Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat , 1999, Journal of Neural Transmission.
[452] S. L. Patrick,et al. Increase in rat striatal extracellular dopamine and vacous chewing produced by two σ receptor ligands , 1993 .
[453] Mustapha Riad,et al. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system , 1996, The Journal of comparative neurology.
[454] K. Sunagawa,et al. Brain Sigma-1 Receptor Stimulation Improves Mental Disorder and Cardiac Function in Mice With Myocardial Infarction , 2013, Journal of cardiovascular pharmacology.
[455] M. R. Iyer,et al. Activation of σ-Receptors Induces Binge-like Drinking in Sardinian Alcohol-Preferring Rats , 2011, Neuropsychopharmacology.
[456] H. Glossmann,et al. High affinity of sigma1‐binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8–C7 isomerase , 1997, British journal of pharmacology.
[457] W. Bowen,et al. Evidence for a multi-site model of the rat brain sigma receptor. , 1989, European journal of pharmacology.
[458] E. Kempner,et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[459] Takanori Hashimoto,et al. Protracted Developmental Trajectories of GABA A Receptor α1 and α2 Subunit Expression in Primate Prefrontal Cortex , 2009, Biological Psychiatry.
[460] M. Jackson,et al. Demonstration of a direct interaction between sigma-1 receptors and acid-sensing ion channels. , 2010, Biophysical journal.
[461] G. Aghajanian,et al. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.
[462] E J Calabrese,et al. Estrogen and Related Compounds: Biphasic Dose Responses , 2001, Critical reviews in toxicology.
[463] R. Blaylock,et al. EXCITOTOXICITY: A POSSIBLE CENTRAL MECHANISM IN FLUORIDE NEUROTOXICITY , 2004 .
[464] S. Kulkarni,et al. Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. , 1998, Neuroreport.
[465] A. Schatzberg,et al. Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486). , 2001, The Journal of clinical endocrinology and metabolism.
[466] E. Nera,et al. The toxicology of domoic acid administered systemically to rodents and primates. , 1990, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada.
[467] P. Chaware,et al. Influence of sigma-1 receptor modulators on ethanol-induced conditioned place preference in the extinction–reinstatement model , 2012, Behavioural pharmacology.
[468] S. Strakowski,et al. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia. , 2000, The Journal of clinical psychiatry.
[469] M. Kassiou,et al. The therapeutic potential of sigma (σ) receptors for the treatment of central nervous system diseases: evaluation of the evidence. , 2012, Current pharmaceutical design.
[470] C. McBain,et al. N-methyl-D-aspartic acid receptor structure and function. , 1994, Physiological reviews.
[471] N. Orentreich,et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. , 1984, The Journal of clinical endocrinology and metabolism.
[472] H. Guard,et al. Hormesis: a response to low environmental concentrations of petroleum hydrocarbons. , 1981, Science.
[473] E. Zorrilla,et al. Late-onset inner retinal dysfunction in mice lacking sigma receptor 1 (σR1). , 2011, Investigative ophthalmology & visual science.
[474] B. Erokwu,et al. The role of excitatory amino acids in airway reflex responses in anesthetized dogs. , 1997, Journal of the autonomic nervous system.
[475] W. Bowen,et al. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. , 1994, European journal of pharmacology.
[476] R. Sapolsky,et al. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death , 2000, Biological Psychiatry.
[477] R. Koehler,et al. Potent sigma1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. , 1998, Stroke.
[478] H. Ueda,et al. Sigma ligands stimulate GTPase activity in mouse prefrontal membranes: evidence for the existence of metabotropic sigma receptor , 1997, Neuroscience Letters.
[479] G. Skuza,et al. The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[480] V. Teichberg. Glial glutamate receptors: likely actors in brain signaling , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[481] J. Musacchio. The psychotomimetic effects of opiates and the sigma receptor. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[482] Nirmal Singh,et al. Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain. , 2011, CNS & neurological disorders drug targets.
[483] I. Guillemain,et al. Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system , 2000, Neuroscience.
[484] J. Awapara,et al. Free gamma-aminobutyric acid in brain. , 1950, The Journal of biological chemistry.
[485] R. Mach,et al. Sigma-2 Receptor as Potential Indicator of Stem Cell Differentiation , 2012, Molecular Imaging and Biology.
[486] F. Fonnum,et al. Stimulation of peripheral cholinergic nerves by glutamate indicates a new peripheral glutamate receptor. , 1989, European journal of pharmacology.
[487] Fangyi Zhang,et al. Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.
[488] P. Romieu,et al. Involvement of the Sigma1 Receptor in the Appetitive Effects of Cocaine , 2004, Pharmacopsychiatry.
[489] T. Kikuchi,et al. 3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives. , 2000, Journal of medicinal chemistry.
[490] P. Casellas,et al. Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. , 2001, Brain research. Molecular brain research.
[491] B. Meldrum. The role of glutamate in epilepsy and other CNS disorders , 1994, Neurology.
[492] G. Pang,et al. Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture. , 1995, European journal of pharmacology.
[493] Sufang Yang,et al. Sigma Receptor Agonists Provide Neuroprotection In Vitro by Preserving bcl-2 , 2007, Anesthesia and analgesia.
[494] J. Kaiser. Sipping From a Poisoned Chalice , 2003, Science.
[495] T. Nabeshima,et al. Enhanced antidepressant efficacy of sigma1 receptor agonists in rats after chronic intracerebroventricular infusion of beta-amyloid-(1-40) protein. , 2004, European Journal of Pharmacology.
[496] Y. Nakata,et al. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain. , 2000, European journal of pharmacology.
[497] T. Yaksh,et al. In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord , 1982, Brain Research.
[498] Eric J. Nestler,et al. Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus , 2000, The Journal of Neuroscience.
[499] M. Jackson,et al. Voltage-gated sodium channel modulation by sigma-receptors in cardiac myocytes and heterologous systems. , 2009, American journal of physiology. Cell physiology.
[500] J. Markley,et al. The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements. , 2012, European journal of pharmacology.
[501] G. Lynch,et al. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466. , 1996, Molecular pharmacology.
[502] N. Newberry,et al. WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones. , 1994, European journal of pharmacology.
[503] B. Derrick,et al. Associative, bidirectional modifications at the hippocampal mossy fibre–CA3 synapse , 1996, Nature.
[504] C. Bergman,et al. Control of NMDA Receptor Activation by a Glycine Transporter Co-Expressed in Xenopus Oocytes , 1997, The Journal of Neuroscience.
[505] Grant C. Churchill,et al. Coordination of agonist-induced Ca2+-signalling patterns by NAADP in pancreatic acinar cells , 1999, Nature.
[506] D. Eyles,et al. Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms , 1994, Psychopharmacology.
[507] V. Ganapathy,et al. Expression, subcellular localization, and regulation of sigma receptor in retinal muller cells. , 2006, Investigative ophthalmology & visual science.
[508] C. Parsons,et al. Glutamate in CNS disorders as a target for drug development: an update. , 1998, Drug news & perspectives.
[509] D. Sinclair. Toward a unified theory of caloric restriction and longevity regulation , 2005, Mechanisms of Ageing and Development.
[510] J. Simpkins,et al. A prototypical Sigma-1 receptor antagonist protects against brain ischemia , 2007, Brain Research.
[511] K. Hashimoto,et al. Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases. , 2012, Current pharmaceutical design.
[512] G. Fond. Utilisation des antidépresseurs de seconde génération (SGA) dans la pratique quotidienne du médecin : une synthèse à l’usage du clinicien , 2013 .
[513] W. Hong,et al. Modulation of bradykinin‐induced calcium changes in SH‐SY5Y cells by neurosteroids and sigma receptor ligands via a shared mechanism , 2004, Synapse.
[514] E. Calabrese. Androgens: Biphasic Dose Responses , 2001, Critical reviews in toxicology.
[515] L. Montoliu,et al. Formalin-induced pain is reduced in sigma(1) receptor knockout mice. , 2005, European journal of pharmacology.
[516] D. Helfman,et al. Cytoskeletal changes in cell transformation and tumorigenesis. , 2001, Current opinion in genetics & development.
[517] I. Guillemain,et al. Differential involvement of the sigma1 (σ1) receptor in the anti‐amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse , 2001, British journal of pharmacology.
[518] D. Sibley,et al. Expression of dopamine D1A receptor gene in proximal tubule of rat kidneys. , 1993, The American journal of physiology.
[519] W. Bowen,et al. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain , 1990, Brain Research.
[520] J. Bockaert,et al. Evidence for a glutamate receptor of the AMPA subtype which mediates insulin release from rat perfused pancreas , 1992, British journal of pharmacology.
[521] E. Arena,et al. Anti‐amnesic properties of (±)‐PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats , 2009, Journal of neurochemistry.
[522] E. J. Mueller,et al. Chinese restaurant syndrome: a review. , 1986, Annals of emergency medicine.
[523] C. Parenti,et al. A new sigma ligand, (+/-)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect. , 2008, Life sciences.
[524] G. Gessa,et al. Distribution of GABA(B) receptor mRNAs in the rat brain and peripheral organs. , 1999, Life sciences.
[525] R. Nicoll,et al. Ca2+ Signaling Requirements for Long-Term Depression in the Hippocampus , 1996, Neuron.
[526] E. Neher,et al. A Ca-dependent early step in the release of catecholamines from adrenal chromaffin cells. , 1993, Science.
[527] C. Broder,et al. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. , 2007, Virus research.
[528] G. Lynch,et al. Failure to detect changes in AMPA receptor binding after long-term potentiation , 1991, Brain Research.
[529] Xiaoyun Guo,et al. Fluvoxamine increased glutamate release by activating both 5-HT(3) and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice. , 2012, Biochimica et biophysica acta.
[530] P. Genever,et al. Evidence for targeted vesicular glutamate exocytosis in osteoblasts. , 2001, Bone.
[531] D. Tauck,et al. Voltage‐dependent conductances of solitary ganglion cells dissociated from the rat retina. , 1987, The Journal of physiology.
[532] R. A. Pearson,et al. Control of cell proliferation by neurotransmitters in the developing vertebrate retina , 2008, Brain Research.
[533] M. Pontecorvo,et al. Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents , 1991, Brain Research Bulletin.
[534] J. Poirier,et al. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. , 1999, Brain research. Molecular brain research.
[535] C. Altar. Neurotrophins and depression. , 1999, Trends in pharmacological sciences.
[536] E. Calabrese. Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. , 2005, Critical reviews in toxicology.
[537] T. Nabeshima,et al. Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities. , 1999, Japanese journal of pharmacology.
[538] Y. Moriyama,et al. Expression and Localization of Vesicular Glutamate Transporters in Pancreatic Islets, Upper Gastrointestinal Tract, and Testis , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[539] M. Mayer,et al. Structure and function of glutamate receptor ion channels. , 2004, Annual review of physiology.
[540] J. A. López-Moreno,et al. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction , 2008, Addiction biology.
[541] S. Wyrick,et al. Putative σ3 sites in mammalian brain have histamine H1 receptor properties: evidence from ligand binding and distribution studies with the novel H1 radioligand [ 3 H ]-(−)-trans-1-phenyl-3-aminotetralin , 1999, Brain Research.
[542] Philip Strange. Function and pharmacology of multiple GABAA receptor subunits , 1992 .
[543] G. Christodoulou,et al. Prolactin secretion in response to haloperidol challenge in delusional (psychotic) and non-delusional depression , 2000, European Psychiatry.
[544] F. Dammacco,et al. Role of active drug transporters in refractory multiple myeloma. , 2009, Current topics in medicinal chemistry.
[545] W. Bowen,et al. Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells. , 1994, Journal of medicinal chemistry.
[546] V. Hruby,et al. Converging Protein Kinase Pathways Mediate Adenylyl Cyclase Superactivation upon Chronic δ-Opioid Agonist Treatment , 2003, Journal of Pharmacology and Experimental Therapeutics.
[547] D. Harder,et al. (+)-Morphine and (-)-morphine stereoselectively attenuate the (-)-morphine-produced tail-flick inhibition via the naloxone-sensitive sigma receptor in the ventral periaqueductal gray of the rat. , 2007, European journal of pharmacology.
[548] F. Artigas,et al. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei , 1993, Synapse.
[549] R. Matsumoto,et al. Review of the pharmacological and clinical profile of rimcazole. , 2006, CNS drug reviews.
[550] Y. Itzhak,et al. Clorgyline displays high affinity for σ binding sites in C57BL/6 mouse brain , 1990 .
[551] G. Debonnel,et al. Pregnancy reduces brain sigma receptor function , 1999, British journal of pharmacology.
[552] B. Meldrum,et al. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. , 2000, The Journal of nutrition.
[553] W. Bowen. Sigma receptors and iboga alkaloids. , 2001, The Alkaloids. Chemistry and biology.
[554] P. Kostyuk,et al. Gating and Permeation of Different Types of Ca Channels , 1989, Annals of the New York Academy of Sciences.
[555] H. Monyer,et al. Glutamate-operated channels: Developmentally early and mature forms arise by alternative splicing , 1991, Neuron.
[556] J. Junien,et al. Evidence for a non-opioid sigma binding site in the guinea-pig myenteric plexus. , 1988, Life sciences.
[557] F. Berardi,et al. The sigma-2 receptor agonist PB28 inhibits calcium release from the endoplasmic reticulum of SK-N-SH neuroblastoma cells. , 2006, Cell calcium.
[558] M. Szatkowski,et al. Contribution of functional voltage‐gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: II. Secretory membrane activity , 2003, Journal of cellular physiology.
[559] E. Calabrese. Adenosine: Biphasic Dose Responses , 2001, Critical reviews in toxicology.
[560] G. Duncan,et al. Silencing of sigma-1 receptor induces cell death in human lens cells. , 2006, Experimental cell research.
[561] P. Ascher,et al. Glycine potentiates the NMDA response in cultured mouse brain neurons , 1987, Nature.
[562] Y. Itzhak. Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: Effects of N-methyl-d-aspartate agonists and antagonists , 1989, Neuroscience Letters.
[563] F. Ghishan,et al. Molecular physiology of vesicular glutamate transporters in the digestive system. , 2005, World journal of gastroenterology.
[564] R. Porter,et al. Anatomy and physiology of glutamate in the CNS , 1994, Neurology.
[565] Robert C. Malenka,et al. Synaptic plasticity in the hippocampus: LTP and LTD , 1994, Cell.
[566] T. Ueda,et al. Phylogenetic studies on the synaptic vesicle glutamate transport system , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[567] W. Bowen,et al. A comparison of (-)-deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests role of sigma 2 receptors in motor function. , 1993, European journal of pharmacology.
[568] D. Attwell,et al. Electrogenic uptake of glutamate and aspartate into glial cells isolated from the salamander (Ambystoma) retina. , 1991, The Journal of physiology.
[569] E. Chatzaki,et al. Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression , 2009, CNS drugs.
[570] E. Seeberg,et al. Cloning and expression of a rat brain L-glutamate transporter , 1992, Nature.
[571] Nidhi Kaushal,et al. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice , 2011, Neuropharmacology.
[572] P. Rosenberg,et al. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex , 1989, Neuroscience Letters.
[573] K. Pennypacker,et al. Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats. , 2006, Current neurovascular research.
[574] P. Casellas,et al. The sigma ligand SR 31747 prevents the development of acute graft-versus-host disease in mice by blocking IFN-gamma and GM-CSF mRNA expression. , 1995, International journal of immunopharmacology.
[575] Antidepressant-like effect of PRE-084, a selective sigma1 receptor agonist, in Albino Swiss and C57BL/6J mice. , 2009, Pharmacological reports : PR.
[576] C. Rampon,et al. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods , 1997, Neuroscience.
[577] R. Glennon,et al. A structure-affinity and comparative molecular field analysis of sigma-2 (sigma2) receptor ligands. , 2009, Central nervous system agents in medicinal chemistry.
[578] L. A. Baldwin,et al. Hormesis: A Generalizable and Unifying Hypothesis , 2001, Critical reviews in toxicology.
[579] W. Bowen,et al. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. , 2002, Cancer research.
[580] S. Lipton,et al. Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.
[581] A. Izzo,et al. Cannabis and cannabinoid receptors. , 2000, Fitoterapia.
[582] Meyer B. Jackson,et al. The Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit , 2002, Neuron.
[583] P. Danks,et al. Neurosteroids modulate calcium currents in hippocampal CA1 neurons via a pertussis toxin-sensitive G-protein-coupled mechanism , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[584] W. Neuhuber,et al. Glutamatergic functions of primary afferent neurons with special emphasis on vagal afferents. , 2007, International review of cytology.
[585] S. Abram,et al. Systemic Opioids Do Not Suppress Spinal Sensitization after Subcutaneous Formalin in Rats , 1994, Anesthesiology.
[586] C. Montigny,et al. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[587] N. Inagaki,et al. Characterization of purification-associated reduction in IgE-dependent histamine release from rat peritoneal mast cells , 1995, Inflammation Research.
[588] T. Bliss,et al. Memories of NMDA receptors and LTP , 1995, Trends in Neurosciences.
[589] M. Lerner,et al. Cocaine Up-Regulates Fra-2 and σ-1 Receptor Gene and Protein Expression in Brain Regions Involved in Addiction and Reward , 2005, Journal of Pharmacology and Experimental Therapeutics.
[590] J. Karlsson,et al. Acute effects of the sigma-2 receptor agonist siramesine on lysosomal and extra-lysosomal proteolytic systems in lens epithelial cells , 2010, Molecular vision.
[591] R. Linden,et al. Glutamate regulates retinal progenitors cells proliferation during development , 2006, The European journal of neuroscience.
[592] M. Kudo,et al. SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression , 2010, Neuroscience Letters.
[593] M. Kassiou,et al. Imaging sigma receptors: applications in drug development. , 2007, Current pharmaceutical design.
[594] G. Debonnel,et al. Modulation of serotonergic neurotransmission by short‐ and long‐term treatments with sigma ligands , 2001, British journal of pharmacology.
[595] K. Gee,et al. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one , 1991, Brain Research.
[596] J. Entrena,et al. Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands , 2008, Current neuropharmacology.
[597] S. Skaper,et al. Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor‐dependent and ‐independent mechanisms , 2004, Journal of neurochemistry.
[598] B. Meldrum. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. , 1990, Cerebrovascular and brain metabolism reviews.
[599] S. Okuyama,et al. Possible expression of a sigma 1 site in rat pheochromocytoma (PC12) cells. , 1996, European Journal of Pharmacology.
[600] Akimichi Kaneko,et al. l-Glutamate-induced responses in OFF-type bipolar cells of the cat retina , 1995, Vision Research.
[601] W. Bowen,et al. Characterization of two novel σ receptor ligands: antidystonic effects in rats suggest σ receptor antagonism , 1995 .
[602] Teruo Hayashi,et al. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. , 2003, The Journal of pharmacology and experimental therapeutics.
[603] F. Battaglia,et al. Glutamine and glutamate exchange between the fetal liver and the placenta. , 2000, The Journal of nutrition.
[604] F. Berardi,et al. Is the sigma2 receptor a histone binding protein? , 2006, Journal of medicinal chemistry.
[605] A. Privat,et al. Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via σ1-receptors , 1997, Behavioural Brain Research.
[606] D. Cheney,et al. Pregnenolone sulfate antagonizes dizocilpine amnesia: role for allopregnanolone , 1995, Neuroreport.
[607] J. Lambert,et al. Neurosteroids: endogenous regulators of the GABAA receptor , 2005, Nature Reviews Neuroscience.
[608] S. Galiègue,et al. SR31747A is a sigma receptor ligand exhibiting antitumoural activity both in vitro and in vivo , 2003, British Journal of Cancer.
[609] Masao Iwase,et al. The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[610] A. Kirchgessner,et al. Localization and function of group III metabotropic glutamate receptors in rat pancreatic islets. , 2002, American journal of physiology. Endocrinology and metabolism.
[611] P. Castillo,et al. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus , 2006, Neuroscience.
[612] P. Skolnick,et al. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine. , 1993, European journal of pharmacology.
[613] T. Yakushiji,et al. Characterization of the currents induced by sigma ligands in NCB20 neuroblastoma cells , 1994, Brain Research.
[614] E. Nera,et al. Neuropathology of experimental domoic acid poisoning in non-human primates and rats. , 1990, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada.
[615] N. Mizushima,et al. Localization of Mammalian NAD(P)H Steroid Dehydrogenase-like Protein on Lipid Droplets* , 2003, Journal of Biological Chemistry.
[616] R. Mach,et al. Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands. , 2012, Surgery.
[617] P. Romieu,et al. Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity , 2002, Neuroscience & Biobehavioral Reviews.
[618] E. Meier,et al. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines. , 1995, Journal of medicinal chemistry.
[619] W. Bowen,et al. Sigma receptors are expressed in human non-small cell lung carcinoma. , 1995, Life sciences.
[620] S. Kulkarni,et al. Sigma (σ1) receptor mediated antidepressant‐like effects of neurosteroids in the Porsolt forced swim test , 1998 .
[621] A. Privat,et al. Sigma1 (σ 1) receptor agonists and neurosteroids attenuate β 25–35-amyloid peptide-induced amnesia in mice through a common mechanism , 1998, Neuroscience.
[622] J. A. Chester,et al. Rewarding Effect of the Neuroactive Steroid 3α-hydroxy-5α-pregnan-20-one in Mice , 1997, Pharmacology Biochemistry and Behavior.
[623] H. Kamiya,et al. Glutamate receptors in the mammalian central nervous system , 1998, Progress in Neurobiology.
[624] M. Hermann,et al. The sigma-1 receptor agonist 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) protects against newborn excitotoxic brain injury by stabilizing the mitochondrial membrane potential in vitro and inhibiting microglial activation in vivo , 2014, Experimental Neurology.
[625] R. Hotchkiss,et al. Sigma-2 ligands induce tumour cell death by multiple signalling pathways , 2012, British Journal of Cancer.
[626] E. Calabrese. 5-Hydroxytryptamine (Serotonin): Biphasic Dose Responses , 2001, Critical reviews in toxicology.
[627] C. Schwartz,et al. Antitussive activity of sigma‐1 receptor agonists in the guinea‐pig , 2004, British journal of pharmacology.
[628] E. A. Schwartz,et al. Electrophysiology of glutamate and sodium co‐transport in a glial cell of the salamander retina. , 1990, The Journal of physiology.
[629] Cha-Min Tang,et al. Expression of Non‐NMDA Glutamate Receptor Channel Genes by Clonal Human Neurons , 1994, Journal of neurochemistry.
[630] A. Marrazzo,et al. Specific κ opioid receptor agonists , 2001 .
[631] W. Bowen,et al. ς1 Receptor-Related Neuroactive Steroids Modulate Cocaine-Induced Reward , 2003, The Journal of Neuroscience.
[632] J. Mikkelsen,et al. Lu 28-179 labels a σ2-site in rat and human brain , 2002, Neuropharmacology.
[633] Kiichi Ishiwata,et al. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[634] S. Yamawaki,et al. β-Estradiol, Dehydroepiandrosterone, and Dehydroepiandrosterone Sulfate Protect against N-Methyl-d-aspartate-Induced Neurotoxicity in Rat Hippocampal Neurons by Different Mechanisms , 2004, Journal of Pharmacology and Experimental Therapeutics.
[635] Teruo Hayashi,et al. Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders , 2011, Expert opinion on therapeutic targets.
[636] M. Hamon,et al. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain , 1984, Brain Research.
[637] A. Hamberger,et al. Cellular Origins of Endogenous Amino Acids Released into the Extracellular Fluid of the Rat Striatum During Severe Insulin‐Induced Hypoglycemia , 1987, Journal of neurochemistry.
[638] G. Pasternak,et al. Potentiation of Opioid Analgesia in Dopamine2Receptor Knock-Out Mice: Evidence for a Tonically Active Anti-Opioid System , 2001, The Journal of Neuroscience.
[639] J. Meunier,et al. Beneficial effects of the sigma1 receptor agonists igmesine and dehydroepiandrosterone against learning impairments in rats prenatally exposed to cocaine. , 2004, Neurotoxicology and teratology.
[640] J. Neale,et al. N‐Acetylaspartylglutamate , 2000, Journal of neurochemistry.
[641] T. Johnson,et al. Modulation of channel function by polyamines. , 1996, Trends in pharmacological sciences.
[642] E. Calabrese. Prostaglandins: biphasic dose responses. , 2001, Critical reviews in toxicology.
[643] A. Guidotti,et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[644] R. Andrew,et al. Spreading depression: imaging and blockade in the rat neocortical brain slice. , 2002, Journal of neurophysiology.
[645] B. Leonard,et al. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor , 1991, Brain Research.
[646] J. Davis,et al. DST studies in psychotic depression: a meta-analysis. , 1997, The American journal of psychiatry.
[647] Y. Zhong,et al. Expression of sigma receptor 1 mRNA and protein in rat retina , 2010, Neuroscience.
[648] T. Su,et al. Sigma‐1 and Sigma‐2 sites in rat brain: Comparison of regional, ontogenetic, and subcellular patterns , 1994, Synapse.
[649] J. Poupaert,et al. Sigma receptors and cocaine abuse. , 2011, Current topics in medicinal chemistry.
[650] S. Lipton,et al. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function , 1995, Neuron.
[651] J. Xu,et al. Cloning and characterization of a mouse sigma1 receptor. , 1998, Journal of neurochemistry.
[652] R. B. Carter,et al. Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. , 1999, Trends in pharmacological sciences.
[653] M. E. Gulden,et al. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors. , 1996, Nuclear medicine and biology.
[654] C. Montigny,et al. Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors. , 1996, The Journal of endocrinology.
[655] K. Hashimoto. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder". , 2009, Journal of clinical psychopharmacology.
[656] M. Djamgoz,et al. Expression profiles of voltage‐gated Na+ channel α‐subunit genes in rat and human prostate cancer cell lines , 2001, The Prostate.
[657] T. Su,et al. Insights into the Sigma‐1 receptor Chaperone's cellular functions: A microarray report , 2012, Synapse.
[658] D. DeHaven-Hudkins,et al. Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain , 1992 .
[659] C. Montigny,et al. Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.
[660] Joshua H. Singer,et al. Fast neurotransmitter release triggered by Ca influx through AMPA-type glutamate receptors , 2006, Nature.
[661] M. Low,et al. K+ channel modulation in rodent neurohypophysial nerve terminals by sigma receptors and not by dopamine receptors , 1999, The Journal of physiology.
[662] E. Baulieu,et al. Neurosteroids: A new brain function? , 1990, The Journal of Steroid Biochemistry and Molecular Biology.
[663] D. Choi. Calcium: still center-stage in hypoxic-ischemic neuronal death , 1995, Trends in Neurosciences.
[664] K. Ishiwata,et al. Cytotoxicity of σ-Receptor Ligands Is Associated with Major Changes of Cellular Metabolism and Complete Occupancy of the σ-2 Subpopulation , 2008, Journal of Nuclear Medicine.
[665] T. Su,et al. A role for sigma receptors in stimulant self-administration and addiction , 2016, Behavioural pharmacology.
[666] O. Pulido,et al. Immunochemical localization of the metabotropic glutamate receptors in the rat heart , 1999, Brain Research Bulletin.
[667] D. Wallace,et al. Sigma binding sites identified by [3H] DTG are elevated in aged Fischer‐344 × Brown Norway (F1) rats , 2000, Synapse.
[668] M. Rennie,et al. Glutamine metabolism and transport in skeletal muscle and heart and their clinical relevance. , 1996, The Journal of nutrition.
[669] C. Montigny,et al. Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.
[670] E. Calabrese. Overcompensation Stimulation: A Mechanism for Hormetic Effects , 2001, Critical reviews in toxicology.
[671] S. Heinemann,et al. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA , 1991, Nature.
[672] K. Matsuno,et al. Ameliorating effects of sigma receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system. , 1994, European journal of pharmacology.
[673] S. Ho,et al. Dextromethorphan potentiates morphine antinociception at the spinal level in rats , 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[674] J. Kamenka,et al. PCP and analogs prevent the proliferative response of T lymphocytes by lowering IL2 production. An effect related to the blockade of mitogen-triggered enhancement of free cytosolic calcium concentration. , 1987, Biochemical pharmacology.
[675] C. Moschovos,et al. Long-term potentiation of high-frequency oscillation and synaptic transmission characterize in vitro NMDA receptor-dependent epileptogenesis in the hippocampus , 2008, Neurobiology of Disease.
[676] E. Smeraldi,et al. Fluvoxamine alone in the treatment of delusional depression. , 1996 .
[677] Y. Itzhak,et al. Clorgyline displays high affinity for sigma binding sites in C57BL/6 mouse brain. , 1990, European journal of pharmacology.
[678] J. Csernansky,et al. Hippocampal atrophy in recurrent major depression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[679] H. Kraemer,et al. Untreated depression and hippocampal volume loss. , 2003, The American journal of psychiatry.
[680] E. Hinoi,et al. Demonstration of expression of mRNA for particular AMPA and kainate receptor subunits in immature and mature cultured rat calvarial osteoblasts , 2002, Brain Research.
[681] R. Hotchkiss,et al. Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy. , 2007, Cancer research.
[682] L. Brandes. Hormetic Effects of Hormones, Antihormones, and Antidepressants on Cancer Cell Growth in Culture: In Vivo Correlates , 2005, Critical reviews in toxicology.
[683] R. Duman,et al. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[684] S. Tam,et al. Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress. , 1999, Life sciences.
[685] M. Ohno,et al. Intrahippocampal administration of (+)-SKF 10,047, a σ ligand, reverses MK-801-induced impairment of working memory in rats , 1995, Brain Research.
[686] C. D. Sharp,et al. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. , 2003, American journal of physiology. Heart and circulatory physiology.
[687] R. Renner. Nietzsche's Toxicology. , 2003 .
[688] L. Cervo,et al. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference , 1995, Brain Research.
[689] Y. Hasin,et al. Apparent desensitization of a σ receptor sub-population in neonatal rat cardiac myocytes by pre-treatment with σ receptor ligands , 1996 .
[690] Dudley Lamming,et al. MicroReview: Small molecules that regulate lifespan: evidence for xenohormesis , 2004, Molecular microbiology.
[691] M. Denavit-Saubié,et al. Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[692] T. Dawson,et al. Nitric oxide synthase in models of focal ischemia. , 1997, Stroke.
[693] S. Okuyama,et al. NE-100, a novel sigma receptor ligand: in vivo tests. , 1993, Life sciences.
[694] J. Junien,et al. Selective stimulation of colonic motor response to a meal by sigma ligands in dogs. , 1990, Gastroenterology.
[695] B. Nilius,et al. Potassium channels and regulation of proliferation of human melanoma cells. , 1992, The Journal of physiology.
[696] E. D. De Souza,et al. Initial identification and characterization of sigma receptors on human peripheral blood leukocytes. , 1988, The Journal of pharmacology and experimental therapeutics.
[697] W Singer,et al. Excitatory amino acid receptors and synaptic plasticity. , 1990, Trends in pharmacological sciences.
[698] C. Slomianny,et al. KV1.1 K(+) channels identification in human breast carcinoma cells: involvement in cell proliferation. , 2000, Biochemical and biophysical research communications.
[699] R. Matsumoto,et al. Interactions between 3,4-methylenedioxymethamphetamine and σ1 Receptors , 2006 .
[700] T. Maurice,et al. Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. , 2000, The Journal of pharmacology and experimental therapeutics.
[701] P. Piazza,et al. Pregnenolone sulfate increases hippocampal acetylcholine release and spatial recognition , 2000, Brain Research.
[702] H. Wassle,et al. Voltage- and transmitter-gated currents of all-amacrine cells in a slice preparation of the rat retina , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[703] H. Meziane,et al. The neurosteroid pregnenolone sulfate reduces learning deficits induced by scopolamine and has promnestic effects in mice performing an appetitive learning task , 1996, Psychopharmacology.
[704] D. B. Vaupel,et al. Naltrexone fails to antagonize the σ effects of PCP and SKF 10,047 in the dog , 1983 .
[705] M. R. Iyer,et al. Antagonism of Sigma-1 Receptors Blocks Compulsive-Like Eating , 2012, Neuropsychopharmacology.
[706] W. Bowen,et al. Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaine. , 1999, European journal of pharmacology.
[707] Kahori Yamada,et al. Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[708] C. Martínez-A,et al. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. , 2001, Annual review of immunology.
[709] D. Choi,et al. Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.
[710] A. R. D. Stebbing. Hormesis: interpreting the β‐curve using control theory , 2000 .
[711] O. Pulido,et al. Review Article: Glutamate Receptors in Peripheral Tissues: Current Knowledge, Future Research, and Implications for Toxicology , 2001, Toxicologic pathology.
[712] J. Arnold. Why sigma-1 receptor dysfunction might confer vulnerability to cannabis-induced psychosis. , 2014, The international journal of neuropsychopharmacology.
[713] D. Zamanillo,et al. Selective sigma-1 (sigma1) receptor antagonists: emerging target for the treatment of neuropathic pain. , 2009, Central nervous system agents in medicinal chemistry.
[714] S. Heinemann,et al. Cloning by functional expression of a member of the glutamate receptor family , 1989, Nature.
[715] T. Su. Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain. , 1982, The Journal of pharmacology and experimental therapeutics.
[716] Tangui Maurice,et al. The pharmacology of sigma-1 receptors. , 2009, Pharmacology & therapeutics.
[717] J. Heym,et al. Sertraline potently displaces (+)-[3H]3-PPP binding to sigma sites in rat brain. , 1989, European journal of pharmacology.
[718] Ted Abel,et al. Molecular mechanisms of memory acquisition, consolidation and retrieval , 2001, Current Opinion in Neurobiology.
[719] E J Calabrese,et al. Historical blunders: how toxicology got the dose-response relationship half right. , 2005, Cellular and molecular biology.
[720] A. Prescott,et al. Sigma receptor antagonists inhibit human lens cell growth and induce pigmentation. , 2005, Investigative ophthalmology & visual science.
[721] V. Ganapathy,et al. Death of retinal neurons in streptozotocin-induced diabetic mice. , 2004, Investigative ophthalmology & visual science.
[722] E. R. Whittemore,et al. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. , 1997, The Journal of pharmacology and experimental therapeutics.
[723] G. Collingridge,et al. The synaptic activation of kainate receptors , 1997, Nature.
[724] M. Vitadello,et al. Distribution of conduction system fibers in the developing and adult rabbit heart revealed by an antineurofilament antibody. , 1989, Circulation research.
[725] A. Delacourte,et al. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. , 2002, The Journal of clinical endocrinology and metabolism.
[726] E. Aydar,et al. The expression and functional characterization of sigma (sigma) 1 receptors in breast cancer cell lines. , 2006, Cancer letters.
[727] W. Singer,et al. Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation , 1993, Trends in Neurosciences.
[728] P. Casellas,et al. Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors , 2000, British Journal of Cancer.
[729] M. Bear,et al. Synaptic plasticity: LTP and LTD , 1994, Current Opinion in Neurobiology.
[730] C. Downes,et al. The σ1 receptor agonist 4-PPBP elicits ERK1/2 phosphorylation in primary neurons: A possible mechanism of neuroprotective action , 2010, Neuropharmacology.
[731] J. Cuevas,et al. Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. , 2002, Journal of neurophysiology.
[732] T. Maurice. Improving Alzheimer's Disease-Related Cognitive Deficits with sigma1 Receptor Agonists. , 2002, Drug news & perspectives.
[733] D. Choi. Excitotoxic cell death. , 1992, Journal of neurobiology.
[734] J. Thompson,et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.
[735] Hideo Tsukada,et al. An increase of sigma1 receptors in the aged monkey brain , 2003, Neurobiology of Aging.
[736] G. Johnston,et al. THE ‘ABC’ OF GABA RECEPTORS: A BRIEF REVIEW , 1999, Clinical and experimental pharmacology & physiology.
[737] H. Chung,et al. Exercise and hormesis: oxidative stress-related adaptation for successful aging , 2004, Biogerontology.
[738] BMY 14802, a Sigma Receptor Ligand for the Treatment of Schizophrenia , 1994, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[739] S. Kulkarni,et al. σ-1 receptors in major depression and anxiety , 2009, Expert review of neurotherapeutics.
[740] P. Robel,et al. Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[741] J. Witkin,et al. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. , 1997, The Journal of pharmacology and experimental therapeutics.
[742] E. London,et al. Divergent ontogeny of sigma and phencyclidine binding sites in the rat brain. , 1989, Brain research. Developmental brain research.
[743] D. Mash,et al. Sigma receptors are associated with cortical limbic areas in the primate brain , 1992, Synapse.
[744] J. D. McGaugh,et al. Effects of post-training bicuculline and muscimol on retention: lack of state dependency. , 1990, Behavioral and neural biology.
[745] M. Prendergast,et al. Inhibition of sigma-1 receptor reduces N-methyl-d-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi , 2010, Neuroscience Letters.
[746] D. W. Parish,et al. PRE-084, a σ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice , 1994, Pharmacology Biochemistry and Behavior.
[747] J. Brosnan. Glutamate, at the interface between amino acid and carbohydrate metabolism. , 2000, The Journal of nutrition.
[748] T. Ishizuka,et al. Expression of a Truncated Form of the Endoplasmic Reticulum Chaperone Protein, σ1 Receptor, Promotes Mitochondrial Energy Depletion and Apoptosis* , 2012, The Journal of Biological Chemistry.
[749] S. Snyder,et al. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. , 1986, The Journal of pharmacology and experimental therapeutics.
[750] D. Kullmann,et al. Extrasynaptic Glutamate Spillover in the Hippocampus: Dependence on Temperature and the Role of Active Glutamate Uptake , 1997, Neuron.
[751] G. Aghajanian,et al. Habenular and other midbrain raphe afferents demonstrated by a modified retrograde tracing technique , 1977, Brain Research.
[752] K. Jeffery,et al. LTP and spatial learning—Where to next? , 1997, Hippocampus.
[753] Bao-Ming Li,et al. Methylphenidate Enhances NMDA-Receptor Response in Medial Prefrontal Cortex via Sigma-1 Receptor: A Novel Mechanism for Methylphenidate Action , 2012, PloS one.
[754] E. Baulieu,et al. Pregnenolone and its sulfate ester in the rat brain , 1983, Brain Research.
[755] D. Zamanillo,et al. Sigma 1 receptor: a new therapeutic target for pain. , 2013, European journal of pharmacology.
[756] E. Costa,et al. Modulation of glutamate receptors by phencyclidine and glycine in the rat cerebellum: cGMP increase in vivo , 1989, Brain Research.
[757] F. Martin,et al. P300 and traffic scenes: The effect of temazepam , 1992, Biological Psychology.
[758] J. Son,et al. The Antinociceptive Effect of Sigma-1 Receptor Antagonist, BD1047, in a Capsaicin Induced Headache Model in Rats. , 2009, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.
[759] I. Katona,et al. Loss of function of the ALS protein SigR1 leads to ER pathology associated with defective autophagy and lipid raft disturbances , 2014, Cell Death and Disease.
[760] X. Codony,et al. Sigma receptors: biology and therapeutic potential , 2004, Psychopharmacology.
[761] R. Hotchkiss,et al. Use of multifunctional sigma-2 receptor ligand conjugates to trigger cancer-selective cell death signaling. , 2012, Cancer research.
[762] E. Kravitz,et al. Release of gamma-aminobutyric acid from inhibitory nerves of lobster. , 1966, Proceedings of the National Academy of Sciences of the United States of America.
[763] H. Betz,et al. Evidence for a Tetrameric Structure of Recombinant NMDA Receptors , 1998, The Journal of Neuroscience.
[764] T. Gudermann,et al. Steroidal Sigma Receptor Ligands Affect Signaling Pathways in Human Spermatozoa1 , 2000, Biology of reproduction.
[765] B. Sakmann,et al. A family of AMPA-selective glutamate receptors. , 1990, Science.
[766] Y. Lee,et al. Effect of excitatory amino acid neurotransmitters on acid secretion in the rat stomach. , 1999, Journal of Biomedical Sciences.
[767] I. Kim,et al. Epidermal Growth Factor and Platelet-derived Growth Factor-BB Induce a Stable Increase in the Activity of Low Density Lipoprotein Receptor-related Protein in Vascular Smooth Muscle Cells by Altering Receptor Distribution and Recycling* , 1996, The Journal of Biological Chemistry.
[768] A. Célérier,et al. Compensatory effect by sigma1 (σ1) receptor stimulation during alcohol withdrawal in mice performing an object recognition task , 2006, Behavioural Brain Research.
[769] Jane S. Paulsen,et al. Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia. , 1996, The American journal of psychiatry.
[770] A. Privat,et al. The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (σ 1) receptors , 1998, Brain Research.
[771] J. Seylaz,et al. The selective inhibitor of neuronal nitric oxide synthase, 7-nitroindazole, reduces the delayed neuronal damage due to forebrain ischemia in rats. , 1998, Stroke.
[772] T. Maurice,et al. The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects. , 2006, Journal of pharmacological sciences.
[773] K. Oh-hashi,et al. Chloroquine inhibits glutamate‐induced death of a neuronal cell line by reducing reactive oxygen species through sigma‐1 receptor , 2011, Journal of neurochemistry.
[774] C. Montigny,et al. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors , 1990 .
[775] R. Marc,et al. Uptake of aspartic and glutamic acid by photoreceptors in goldfish retina. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[776] N. Orentreich,et al. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. , 1992, The Journal of clinical endocrinology and metabolism.
[777] M. Aschner,et al. The importance of glutamate, glycine, and gamma-aminobutyric acid transport and regulation in manganese, mercury and lead neurotoxicity. , 2005, Toxicology and applied pharmacology.
[778] C. Montigny,et al. Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[779] M. Yuzaki. New insights into the structure and function of glutamate receptors: the orphan receptor delta2 reveals its family's secrets. , 2003, The Keio journal of medicine.
[780] M. Hajós,et al. An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat , 1998, Neuroscience.
[781] S. Kourrich,et al. The sigma-1 receptor: roles in neuronal plasticity and disease , 2012, Trends in Neurosciences.
[782] D. Schoepp,et al. Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.
[783] V. Dawson,et al. Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. , 2001, Stroke.
[784] Y. Yoneda,et al. Localization of [3H]glutamate binding sites in rat adrenal medulla , 1986, Brain Research.
[785] P. Romieu,et al. Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity. , 2002, Neuroscience and biobehavioral reviews.
[786] B. Cagniard,et al. The neurosteroid pregnenolone sulfate blocks deficits induced by a competitive NMDA antagonist in active avoidance and lever-press learning tasks in mice , 1996, Neuropharmacology.
[787] D. Greenberg,et al. Dextromethorphan and dextrorphan as calcium channel antagonists , 1988, Brain Research.
[788] Anne W. Schmidt,et al. Sertraline potently displaces (+)-[3H]3-PPP binding to σ sites in rat brain , 1989 .
[789] J. Hada,et al. 7-Nitroindazole reduces nitric oxide concentration in rat hippocampus after transient forebrain ischemia. , 1999, European journal of pharmacology.
[790] A. Alavi,et al. N-(n-Benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: a potential ligand for PET imaging of breast cancer. , 2000, Nuclear Medicine and Biology.
[791] R. Dingledine,et al. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. , 1988, Science.
[792] D. Zamanillo,et al. Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice. , 2003, The European journal of neuroscience.
[793] K. Ishii,et al. Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility study. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[794] A. Graybiel,et al. Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the cat , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[795] J. Mallol,et al. Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers , 2013, PloS one.
[796] G. Skuza. Potential antidepressant activity of sigma ligands. , 2003, Polish journal of pharmacology.
[797] E. Calabrese. Adrenergic Receptors: Biphasic Dose Responses , 2001, Critical reviews in toxicology.
[798] J. A. Peters,et al. Neurosteroid modulation of native and recombinant GABAA receptors , 1996, Cellular and Molecular Neurobiology.
[799] D. Rusakov,et al. Receptor actions of synaptically released glutamate: the role of transporters on the scale from nanometers to microns. , 2008, Biophysical journal.
[800] E. Calabrese. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences. , 2005, Environmental pollution.
[801] T. Hudzik,et al. Sigma receptor-mediated emetic response in pigeons: agonists, antagonists and modifiers. , 1993, European journal of pharmacology.
[802] M. Hollmann,et al. Molecular neurobiology of glutamate receptors. , 1992, Annual review of physiology.
[803] Y. Minabe,et al. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. , 1996, European journal of pharmacology.
[804] A. Beitz,et al. An increase in spinal dehydroepiandrosterone sulfate (DHEAS) enhances NMDA-induced pain via phosphorylation of the NR1 subunit in mice: Involvement of the sigma-1 receptor , 2010, Neuropharmacology.
[805] D. Zamanillo,et al. Immunohistochemical localization of the σ1-receptor in oligodendrocytes in the rat central nervous system , 2003, Brain Research.
[806] J. Mikkelsen,et al. Lu 28-179 labels a sigma(2)-site in rat and human brain. , 2002, Neuropharmacology.
[807] D. Schoepp. Novel functions for subtypes of metabotropic glutamate receptors , 1994, Neurochemistry International.
[808] R. Renner. Hormesis. Nietzsche's toxicology. , 2003, Scientific American.
[809] N. Harrison,et al. Modulation of the GABA receptor complex by a steroid anaesthetic , 1984, Brain Research.
[810] Li-Yan Xu,et al. Overexpression of Sigma1 Receptor and Its Positive Associations With Pathologic TNM Classification in Esophageal Squamous Cell Carcinoma , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[811] F. Fonnum,et al. Amino acid neurotransmission: Dynamics of vesicular uptake , 1996, Neurochemical Research.
[812] V. Ganapathy,et al. Exon‐Intron Structure, Analysis of Promoter Region, and Chromosomal Localization of the Human Type 1 σ Receptor Gene , 1998, Journal of neurochemistry.
[813] Claudette Boni,et al. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine , 2000, Neuropharmacology.
[814] R. Matsumoto. Targeting sigma receptors: novel medication development for drug abuse and addiction , 2009, Expert review of clinical pharmacology.
[815] C. Montigny,et al. Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors , 1985, Neuroscience.
[816] W. Bowen,et al. Evidence for a multi-site model of the rat brain σ receptor , 1989 .
[817] J. Meunier,et al. Pharmacological interaction with the sigma1 (σ1)-receptor in the acute behavioral effects of antidepressants. , 2011, Journal of pharmacological sciences.
[818] M. Hiramatsu,et al. Improvement of memory impairment by (+)- and (−)-pentazocine via sigma, but not kappa opioid receptors , 2005, Brain Research.
[819] E. Delay,et al. The Taste of Monosodium Glutamate: Membrane Receptors in Taste Buds , 1996, The Journal of Neuroscience.
[820] N. Mjellem,et al. Reduction of NMDA-induced behaviour after acute and chronic administration of desipramine in mice , 1993, Neuropharmacology.
[821] K. Sunagawa,et al. Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression. , 2012, Cardiovascular research.
[822] R. Dingledine,et al. The glutamate receptor ion channels. , 1999, Pharmacological reviews.
[823] C. Montigny,et al. Modification of the N-methyl-D-aspartate response by antidepressant σ receptor ligands , 1993 .
[824] D. DeHaven-Hudkins,et al. Allosteric modulation of ligand binding to [3H](+)pentazocine-defined sigma recognition sites by phenytoin. , 1993, Life sciences.
[825] G. Pepe,et al. A comparative study of serum progesterone levels in pregnancy and in various types of pseudopregnancy in the rat. , 1974, Endocrinology.
[826] C. Montigny,et al. Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders. , 1996, Life sciences.
[827] P. Dunkley,et al. Intrasynaptosomal free calcium levels in rat forebrain synaptosomes: modulation by sigma (σ) receptor ligands , 1996, Neuroscience Letters.
[828] H. Toresson,et al. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. , 2011, Brain : a journal of neurology.
[829] W. Singer,et al. Calcium-induced long-term depression in the visual cortex of the rat in vitro. , 1996, Journal of neurophysiology.
[830] H. Cantiello,et al. Actin-binding protein contributes to cell volume regulatory ion channel activation in melanoma cells. , 1993, Journal of Biological Chemistry.
[831] A. Privat,et al. The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (σ) receptor ligands involves both σ1 and σ2 sites , 1999 .
[832] S. Fukushima,et al. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens. , 2005, Carcinogenesis.
[833] M. Pontecorvo,et al. Selective sigma ligands block stimulant effects of cocaine. , 1991, European journal of pharmacology.
[834] J. Vela,et al. Selective sigma-1 receptor antagonists for the treatment of pain. , 2014, Future medicinal chemistry.
[835] K. Todd,et al. Moving past the "neuroncentric" perspective: a role for glia in neuropsychiatric disorders. , 2009, Journal of psychiatry & neuroscience : JPN.
[836] G. Pasternak,et al. Cloning and Characterization of a Mouse σ1 Receptor , 1998 .
[837] Frances A. Edwards,et al. LTP — a structural model to explain the inconsistencies , 1995, Trends in Neurosciences.
[838] C. Woolley,et al. Steroid hormones as mediators of neural plasticity , 1991, The Journal of Steroid Biochemistry and Molecular Biology.
[839] P. Hochstrate,et al. Distribution and functional properties of glutamate receptors in the leech central nervous system. , 1996, Journal of neurophysiology.
[840] T. Nabeshima,et al. Enhanced antidepressant efficacy of σ1 receptor agonists in rats after chronic intracerebroventricular infusion of β-amyloid-(1–40) protein , 2004 .
[841] T. Su,et al. Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine , 2004, The European journal of neuroscience.
[842] E. London,et al. Response : Steroid Binding at σ-"Opioid" Receptors , 1989 .
[843] J. Maloteaux,et al. Neuroleptic binding to sigma receptors: Possible involvement in neuroleptic-induced acute dystonia , 1997, Biological Psychiatry.
[844] M. Ohyama,et al. Low density of sigma1 receptors in early Alzheimer’s disease , 2008, Annals of nuclear medicine.
[845] S. Galiègue,et al. Purification and Characterization of the Human SR 31747A-binding Protein , 1997, The Journal of Biological Chemistry.
[846] M. Erlander,et al. Two genes encode distinct glutamate decarboxylases , 1991, Neuron.
[847] J. Grisel,et al. The influence of dextromethorphan on morphine analgesia in Swiss Webster mice is sex-specific , 2005, Pharmacology Biochemistry and Behavior.
[848] K. Abe,et al. Epidermal growth factor selectively enhances NMDA receptor-mediated increase of intracellular Ca2+ concentration in rat hippocampal neurons , 1992, Brain Research.
[849] L. Lanfumey,et al. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.
[850] D. Roh,et al. Activation of the spinal sigma‐1 receptor enhances NMDA‐induced pain via PKC‐ and PKA‐dependent phosphorylation of the NR1 subunit in mice , 2008, British journal of pharmacology.
[851] Z. Vogel,et al. Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes. , 1994, The Journal of pharmacology and experimental therapeutics.
[852] M. Pumarola,et al. Immunohistochemical localization of the sigma1 receptor in Schwann cells of rat sciatic nerve , 2004, Brain Research.
[853] W Singer,et al. Different threshold levels of postsynaptic [Ca2+]i have to be reached to induce LTP and LTD in neocortical pyramidal cells , 1996, Journal of Physiology-Paris.
[854] M. Maiuri,et al. Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect , 2013, Front. Pharmacol..
[855] L. Shenkman,et al. Haloperidol‐induced syndrome of inappropriate secretion of antidiuretic hormone , 1979, Clinical pharmacology and therapeutics.
[856] B. Slusher,et al. Design of NAALADase inhibitors: a novel neuroprotective strategy. , 2001, Current medicinal chemistry.
[857] W. Bowen,et al. A proposal for the classification of sigma binding sites. , 1992, Trends in pharmacological sciences.
[858] D. Bitrán,et al. Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. , 1991, Brain research.
[859] J. Junien,et al. JO1784, a novel σ ligand, potentiates [3H]acetylcholine release from rat hippocampal slices , 1991 .
[860] K. Mackie,et al. Cannabinoid Receptors: Where They are and What They do , 2008, Journal of neuroendocrinology.
[861] F. Kirchhoff,et al. NMDA Receptors in Glia , 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[862] Y. Hirayasu,et al. Localized Potentiation of Sleep Slow-Wave Activity Induced by Prefrontal Repetitive Transcranial Magnetic Stimulation in Patients with a Major Depressive Episode , 2013, Brain Stimulation.
[863] Teruo Hayashi,et al. Regulating ankyrin dynamics: Roles of sigma-1 receptors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[864] J. Dolly,et al. Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation , 2003, Pflügers Archiv.
[865] G. Debonnel,et al. In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. , 1992, The Journal of pharmacology and experimental therapeutics.
[866] J. Ludovic Croxford,et al. Therapeutic Potential of Cannabinoids in CNS Disease , 2003, CNS drugs.
[867] F. Borsini,et al. The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex , 1994, Neuropharmacology.
[868] T. Su. Delineating biochemical and functional properties of sigma receptors: emerging concepts. , 1993, Critical reviews in neurobiology.
[869] D. Helmeste,et al. Misinterpretation of facial expression: A cross‐cultural study , 1999, Psychiatry and clinical neurosciences.
[870] E J Calabrese,et al. Defining hormesis , 2002, Human & experimental toxicology.
[871] V. Papadopoulos,et al. Evidence for sigma‐1‐like receptors in isolated rat liver mitochondrial membranes , 2002, British journal of pharmacology.
[872] Jun-Hai Yang,et al. Characterization of Glutamate Transporter Function in the Tiger Salamander Retina , 1997, Vision Research.
[873] S. Said,et al. Glutamate receptors and asthmatic airway disease. , 1999, Trends in pharmacological sciences.
[874] Howard E. Gendelman,et al. Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .
[875] T. Nabeshima,et al. Stress-induced behavioral responses and multiple opioid systems in the brain , 1995, Behavioural Brain Research.
[876] F. Holsboer,et al. Progesterone receptor-mediated effects of neuroactive steroids , 1993, Neuron.
[877] J. Blalock,et al. Functional assessment and partial characterization of [3H](+)-pentazocine binding sites on cells of the immune system , 1991, Journal of Neuroimmunology.
[878] Tetsuya Kobayashi,et al. σ1 Receptor Subtype Is Involved in the Facilitation of Cortical Dopaminergic Transmission in the Rat Brain , 1997, Neurochemical Research.
[879] G. Ponzio,et al. Inhibition of Tumor Cell Proliferation by σ Ligands Is Associated with K+ Channel Inhibition and p27kip1 Accumulation , 2004, Journal of Pharmacology and Experimental Therapeutics.
[880] Marcia Firmani,et al. Low Concentrations of Nitric Oxide Exert a Hormetic Effect on Mycobacterium tuberculosis In Vitro , 2005, Journal of Clinical Microbiology.
[881] E. Smeraldi,et al. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. , 1996, The American journal of psychiatry.
[882] T. B. Taylor,et al. Neuroexcitatory and neurotoxic actions of the amnesic shellfish poison, domoic acid. , 1994, Neuroreport.
[883] L. Suva,et al. Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents? , 1997, Bone.
[884] B. Diamond,et al. Does sigma receptor antagonism predict clinical antipsychotic efficacy? , 1991, Psychopharmacology bulletin.
[885] C. Rousseaux. A Review of Glutamate Receptors II: Pathophysiology and Pathology , 2008 .
[886] E. Meririnne,et al. The Effects of Diazepam and Zolpidem on Cocaine- and Amphetamine-Induced Place Preference , 1999, Pharmacology Biochemistry and Behavior.
[887] S. Okuyama,et al. Possible expression of a σ1 site in rat pheochromocytoma (PC12) cells , 1996 .
[888] Teruo Hayashi,et al. Protein Kinase A Activation Down-Regulates, Whereas Extracellular Signal-Regulated Kinase Activation Up-Regulates σ-1 Receptors in B-104 Cells: Implication for Neuroplasticity , 2007, Journal of Pharmacology and Experimental Therapeutics.
[889] E. Calabrese. Apoptosis: Biphasic Dose Responses , 2001, Critical Reviews in Toxicology.
[890] C. Stevens,et al. Cloning of a putative glutamate receptor: A low affinity kainate-binding subunit , 1992, Neuron.
[891] B. Wünsch,et al. Expression of σ receptors of human urinary bladder tumor cells (RT-4 cells) and development of a competitive receptor binding assay for the determination of ligand affinity to human σ(2) receptors. , 2011, Journal of pharmaceutical and biomedical analysis.
[892] M. Kilberg,et al. Molecular biology of mammalian amino acid transporters. , 1996, Annual review of biochemistry.
[893] C. Foster,et al. Differential expression of voltage‐activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro , 1995, FEBS Letters.
[894] Alan F. Schatzberg,et al. Rapid Reversal of Psychotic Depression Using Mifepristone , 2001, Journal of clinical psychopharmacology.
[895] M. Schumacher,et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system , 2003, Progress in Neurobiology.
[896] T. Dermody,et al. Reovirus nonstructural protein σ1s is required for establishment of viremia and systemic dissemination , 2009, Proceedings of the National Academy of Sciences.
[897] K. Matsuno,et al. Increase of extracellular acetylcholine level in rat frontal cortex induced by (+)N-allylnormetazocine as measured by brain microdialysis , 1992, Brain Research.
[898] P. Flamen,et al. Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer. , 1997, Anticancer research.
[899] M. Frosch,et al. Responses mediated by excitatory amino acid receptors in solitary retinal ganglion cells from rat. , 1988, The Journal of physiology.
[900] Xin Cai,et al. Quantitative analysis of the fate of gold nanocages in vitro and in vivo after uptake by U87-MG tumor cells. , 2013, Angewandte Chemie.
[901] O. Sürücü,et al. Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. , 2005, Cancer research.
[902] M. Watters. Organic neurotoxins in seafoods , 1995, Clinical Neurology and Neurosurgery.
[903] R. Hampson,et al. Cannabinoid receptors: G-protein-mediated signal transduction mechanisms. , 1993, Biochemical Society symposium.
[904] L. Cazin,et al. Gramicidin‐perforated patch revealed depolarizing effect of GABA in cultured frog melanotrophs , 1998, The Journal of physiology.
[905] W. Bowen,et al. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. , 1995, Cancer research.
[906] L. Pozzi,et al. Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats , 1991, Neuropharmacology.
[907] Kiichi Ishiwata,et al. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. , 2006, Current pharmaceutical design.
[908] S. Fukushima,et al. Alpha-benzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes. , 2006, Cancer letters.
[909] G. Simpson,et al. An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression. , 2005, The Journal of clinical psychiatry.
[910] S. A. Bura,et al. Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects. , 2013, European journal of pharmacology.
[911] K. Ishiwata,et al. Evaluation of [11C]SA5845 and [11C]SA4503 for imaging of sigma receptors in tumors by animal PET , 2005, Annals of nuclear medicine.
[912] K. Fukunaga,et al. Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection , 2011, Expert opinion on therapeutic targets.
[913] D. Attwell,et al. Electrogenic glutamate uptake in glial cells is activated by intracellular potassium , 1988, Nature.
[914] K. Pennypacker,et al. Sigma receptors suppress multiple aspects of microglial activation , 2009, Glia.
[915] K. Pennypacker,et al. Administration of a Sigma Receptor Agonist Delays MCAO-Induced Neurodegeneration and White Matter Injury , 2010, Translational Stroke Research.
[916] J. T. Hackett,et al. Regulation of the Neuronal Nicotinic Acetylcholine Receptor by Src Family Tyrosine Kinases* , 2004, Journal of Biological Chemistry.
[917] J. Wadiche,et al. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[918] A. Steiger,et al. Open clinical trial on the sigma ligand panamesine in patients with schizophrenia , 1997, Psychopharmacology.
[919] J. Pin,et al. Pharmacology and functions of metabotropic glutamate receptors. , 1997, Annual review of pharmacology and toxicology.
[920] G. Alexopoulos,et al. Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression , 1999, Biological Psychiatry.
[921] S. Safrany,et al. Antagonists show GTP‐sensitive high‐affinity binding to the sigma‐1 receptor , 2011, British journal of pharmacology.
[922] D. DeHaven-Hudkins,et al. Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain. , 1992, European journal of pharmacology.
[923] W. Bowen,et al. σ Binding parameters in developing rats predict behavioral efficacy of a σ ligand , 1993, Brain Research.
[924] G. Skuza,et al. A potential antidepressant activity of SA4503, a selective sigma 1 receptor agonist. , 2002, Behavioural pharmacology.
[925] S. Paul,et al. Pregnenolone sulfate augments NMDA receptor mediated increases in intracellular Ca2+ in cultured rat hippocampal neurons , 1992, Neuroscience Letters.
[926] S. Yamawaki,et al. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons. , 1995, The Journal of pharmacology and experimental therapeutics.
[927] Teruo Hayashi,et al. An update on the development of drugs for neuropsychiatric disorders: focusing on the σ1 receptor ligand , 2008, Expert opinion on therapeutic targets.
[928] T. Nabeshima,et al. Age‐related expression of σ1 receptors and antidepressant efficacy of a selective agonist in the senescence‐accelerated (SAM) mouse , 2005, Journal of neuroscience research.
[929] J. Wu,et al. Effect of L‐glutamic acid on acid secretion and immunohistochemical localization of glutamatergic neurons in the rat stomach , 1994, Journal of neuroscience research.
[930] E. Smeraldi,et al. Long‐term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study , 1997, International clinical psychopharmacology.
[931] S. Rattan. Hormetic mechanisms of anti-aging and rejuvenating effects of repeated mild heat stress on human fibroblasts in vitro. , 2004, Rejuvenation research.
[932] B. Stoffel‐Wagner. Neurosteroid Biosynthesis in the Human Brain and Its Clinical Implications , 2003, Annals of the New York Academy of Sciences.
[933] Gianluca Bontempi,et al. 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. , 2007, Neoplasia.
[934] G. Simpson,et al. Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression. , 2003, The Journal of clinical psychiatry.
[935] R. Yoshimura,et al. Association analysis of SIGMAR1 with major depressive disorder and SSRI response , 2010, Neuropharmacology.
[936] K. Dutschka,et al. In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA). , 1999, Nuclear medicine and biology.
[937] D. Jeste. Alzheimer's Disease: Optimizing Drug Development Strategies , 1996 .
[938] H. Simon,et al. Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat , 1993, Brain Research.
[939] G. Debonnel. Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry. , 1993, Journal of psychiatry & neuroscience : JPN.
[940] P. Genever,et al. Regulation of spontaneous glutamate release activity in osteoblastic cells and its role in differentiation and survival: evidence for intrinsic glutamatergic signaling in bone , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[941] A. Niijima,et al. Reflex effects of oral, gastrointestinal and hepatoportal glutamate sensors on vagal nerve activity. , 2000, The Journal of nutrition.
[942] G. Koob,et al. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors , 1997 .
[943] Prakash S Masan. Atypical antipsychotics in the treatment of affective symptoms: a review. , 2004, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[944] M. Jackson,et al. Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels. , 2011, American journal of physiology. Cell physiology.
[945] A. Flint,et al. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT , 1998, International journal of geriatric psychiatry.
[946] L. Kaczmarek,et al. Rapid Phosphorylation of Elk-1 Transcription Factor and Activation of MAP Kinase Signal Transduction Pathways in Response to Visual Stimulation , 1999, Molecular and Cellular Neuroscience.
[947] W. Bowen,et al. Differentiation of σ ligand‐activated receptor subtypes that modulate NMDA‐evoked [3H]‐noradrenaline release in rat hippocampal slices , 1996 .
[948] G. Aghajanian,et al. Tryptophan-deficient diet and amino acid drink deplete plasma tryptophan and induce a relapse of depression in susceptible patients , 1992, Journal of Chemical Neuroanatomy.
[949] S. Homan,et al. Overexpression of σ Receptors in Nonneural Human Tumors , 1991 .
[950] A. Araque,et al. Endocannabinoids Mediate Neuron-Astrocyte Communication , 2008, Neuron.
[951] R. Pechnick. Effects of opioids on the hypothalamo-pituitary-adrenal axis. , 1993, Annual review of pharmacology and toxicology.
[952] S. Smith. Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells , 1991, Neuroscience.
[953] M. Djamgoz,et al. Effects of voltage‐gated ion channel modulators on rat prostatic cancer cell proliferation: Comparison of strongly and weakly metastatic cell lines , 2000, The Prostate.
[954] S. Kulkarni,et al. Possible involvement of sigma‐1 receptors in the anti‐immobility action of bupropion, a dopamine reuptake inhibitor , 2008, Fundamental & clinical pharmacology.
[955] M. Moskowitz,et al. Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.
[956] A. Urani,et al. Enhanced antidepressant effect of sigma1 (σ1) receptor agonists in β25–35-amyloid peptide-treated mice , 2002, Behavioural Brain Research.
[957] M. Ballabio,et al. Neuroactive steroids , 2007, Journal of Molecular Neuroscience.
[958] W. Bowen,et al. Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity. , 1995, European Journal of Pharmacology.
[959] J. Miyazaki,et al. Functional neuronal ionotropic glutamate receptors are expressed in the non-neuronal cell line MIN6. , 1994, The Journal of biological chemistry.
[960] V. Ganapathy,et al. Cocaine-sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells. , 1995, Endocrinology.
[961] T. Nishikawa,et al. p-chlorophenylalanine-reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain. , 1993, European journal of pharmacology.
[962] G. Debonnel,et al. Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors , 1997, Psychopharmacology.
[963] D. Allen,et al. Monosodium L-glutamate-induced asthma. , 1987, The Journal of allergy and clinical immunology.
[964] F. Werblin,et al. Characterization of the glutamate transporter in retinal cones of the tiger salamander , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[965] E. Calabrese,et al. The frequency of U-shaped dose responses in the toxicological literature. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[966] M. Aceto,et al. Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties. , 1994, Journal of medicinal chemistry.
[967] T. Kudo,et al. Sigma-1Rs are upregulated via PERK/eIF2α/ATF4 pathway and execute protective function in ER stress. , 2011, Biochemical and biophysical research communications.
[968] R. Campbell,et al. Aspartate and glutamate modulation of growth hormone secretion in the pig: possible site of action. , 1996, Domestic animal endocrinology.
[969] K. Ishiwata,et al. Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands. , 2010, Current pharmaceutical design.
[970] A. Urani,et al. Strain differences in σ1 receptor‐mediated behaviours are related to neurosteroid levels , 2002 .
[971] M. Roth,et al. Cocaine modulates cytokine and enhances tumor growth through sigma receptors , 2004, Journal of Neuroimmunology.
[972] D. Demêmes,et al. Cellular and subcellular localization of AMPA-selective glutamate receptors in the mammalian peripheral vestibular system , 1995, Brain Research.
[973] I. Lucki,et al. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. , 1995, The Journal of pharmacology and experimental therapeutics.
[974] S. Snyder,et al. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1- propyl)piperidine , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[975] V. Ganapathy,et al. Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. , 1999, The Journal of pharmacology and experimental therapeutics.
[976] L. Cazin,et al. Sigma ligands stimulate the electrical activity of frog pituitary melanotrope cells through a G-protein-dependent inhibition of potassium conductances. , 1998, The Journal of pharmacology and experimental therapeutics.
[977] E. Hinoi,et al. Consolidation of transient ionotropic glutamate signals through nuclear transcription factors in the brain , 2001, Progress in Neurobiology.
[978] M. Starr. Antiparkinsonian actions of glutamate antagonists — alone and with L-DOPA: A review of evidence and suggestions for possible mechanisms , 1995, Journal of neural transmission. Parkinson's disease and dementia section.
[979] K. Krnjević,et al. Chemical Nature of Synaptic Transmission in Vertebrates , 1974 .
[980] K. Ishiwata,et al. Imaging of sigma1 receptors in the human brain using PET and [11C]SA4503. , 2009, Central nervous system agents in medicinal chemistry.
[981] C. Montigny,et al. The effects of sigma ligands and of neuropeptide Y on N‐methyl‐d‐aspartate‐induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin , 1994, British journal of pharmacology.
[982] G. Pasternak,et al. Modulation of Brainstem Opiate Analgesia in the Rat by σ1 Receptors: A Microinjection Study , 2007, Journal of Pharmacology and Experimental Therapeutics.
[983] David R. Brown. Neurons Depend on Astrocytes in a Coculture System for Protection from Glutamate Toxicity , 1999, Molecular and Cellular Neuroscience.
[984] G. Pasternak,et al. Modulation of brainstem opiate analgesia in the rat by sigma 1 receptors: a microinjection study. , 2007, The Journal of pharmacology and experimental therapeutics.
[985] Teruo Hayashi,et al. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. , 2003, Current medicinal chemistry.
[986] Su Tp,et al. Delineating biochemical and functional properties of sigma receptors: emerging concepts. , 1993 .
[987] S. Rattan. Mechanisms of Hormesis through Mild Heat Stress on Human Cells , 2004, Annals of the New York Academy of Sciences.
[988] Rupal M Mody,et al. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C. , 2002, The Journal of pharmacology and experimental therapeutics.
[989] M. Beal,et al. Aging, energy, and oxidative stress in neurodegenerative diseases , 1995, Annals of neurology.
[990] Shuxin Li,et al. Mechanisms of Ionotropic Glutamate Receptor-Mediated Excitotoxicity in Isolated Spinal Cord White Matter , 2000, The Journal of Neuroscience.
[991] S. Goldberg,et al. Regulation of σ-1 Receptors and Endoplasmic Reticulum Chaperones in the Brain of Methamphetamine Self-Administering Rats , 2010, Journal of Pharmacology and Experimental Therapeutics.
[992] Sarah L Parylak,et al. Sigma-1 receptor knockout mice display a depressive-like phenotype , 2009, Behavioural Brain Research.
[993] S. Buch,et al. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. , 2010, Trends in pharmacological sciences.
[994] K. E. Moore,et al. The σ receptor ligand rimcazole alters secretion of prolactin and α-melanocyte stimulating hormone by dopaminergic and non-dopaminergic mechanisms , 1996 .
[995] L. Suva,et al. Expression of an N-methyl-D-aspartate-type receptor by human and rat osteoblasts and osteoclasts suggests a novel glutamate signaling pathway in bone. , 1998, Bone.
[996] R. Nicoll,et al. Synaptic plasticity and dynamic modulation of the postsynaptic membrane , 2000, Nature Neuroscience.
[997] Q. Pittman,et al. Cannabinoid CB(2) receptors in health and disease. , 2010, Current medicinal chemistry.
[998] C. Jahr,et al. Retinal glial cell glutamate transporter is coupled to an anionic conductance. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[999] M. Tohen,et al. Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. , 2000, The Journal of clinical psychiatry.
[1000] S. Okuyama,et al. [Physiological function of sigma receptors: central pharmacological effects of sigma ligands]. , 1994, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology.
[1001] E. Hinoi,et al. Group III metabotropic glutamate receptors in rat cultured calvarial osteoblasts. , 2001, Biochemical and biophysical research communications.
[1002] P. Seeburg,et al. Mammalian ionotropic glutamate receptors , 1993, Current Opinion in Neurobiology.
[1003] Teruo Hayashi,et al. σ‐1 Receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: Potential relation to lipid raft reconstitution , 2004, Synapse.
[1004] J. Henley,et al. Kainate receptors: subunits, synaptic localization and function. , 1999, Trends in pharmacological sciences.
[1005] K. Matsuno,et al. Possible involvement of a sigma receptor subtype in the neck dystonia in rats. , 1999, Pharmacology, biochemistry, and behavior.
[1006] C. Mazure,et al. Psychotic depression and mortality. , 2003, The American journal of psychiatry.
[1007] P. Ince,et al. Glutamate, excitotoxicity and amyotrophic lateral sclerosis , 1997, Journal of Neurology.
[1008] A. Coop,et al. Attenuation of methamphetamine-induced effects through the antagonism of sigma (σ) receptors: Evidence from in vivo and in vitro studies , 2008, European Neuropsychopharmacology.
[1009] Christian Rosenmund,et al. Heteromeric AMPA Receptors Assemble with a Preferred Subunit Stoichiometry and Spatial Arrangement , 2001, Neuron.
[1010] G. Wittenberg,et al. Neurosteroid regulation of inhibitory synaptic transmission in the rat hippocampus in vitro , 1999, Neuroscience.
[1011] K. Hashimoto,et al. Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease , 2010, Annals of general psychiatry.
[1012] P. Romieu,et al. Involvement of the σ1 receptor in the cocaine‐induced conditioned place preference , 2000 .
[1013] Yvette I. Sheline,et al. Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression , 1999, The Journal of Neuroscience.
[1014] S. Yamada,et al. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors , 2005, British journal of pharmacology.
[1015] P. Schofield,et al. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration–motor neuron disease , 2010, Annals of neurology.
[1016] E. London,et al. Alterations in local cerebral glucose utilization induced by phencyclidine , 1987, Brain Research.
[1017] D. B. Vaupel,et al. Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog. , 1983, European journal of pharmacology.
[1018] R. Scobey,et al. Permeation of calcium ions through non-NMDA glutamate channels in retinal bipolar cells. , 1991, Science.
[1019] G. Debonnel,et al. Gender and gonadal status modulation of dorsal raphe nucleus serotonergic neurons. Part I: Effects of gender and pregnancy , 2002, Neuropharmacology.
[1020] M. Papp,et al. The selective σ2 ligand Lu 28‐179 has an antidepressant‐like profile in the rat chronic mild stress model of depression , 2000, Behavioural pharmacology.
[1021] W. Lehmann,et al. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization. , 2000, Journal of medicinal chemistry.
[1022] M. Lev,et al. The Dissection of the Atrioventricular Node Bundle and Bundle Branches in the Human Heart , 1951, Circulation.
[1023] B. de Costa,et al. Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[1024] A. Vasku,et al. Modulation of expression of the sigma receptors in the heart of rat and mouse in normal and pathological conditions. , 2007, General physiology and biophysics.
[1025] Suzie Chen,et al. Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development , 2004, Journal of Molecular Medicine.
[1026] C. Montigny,et al. Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency , 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.
[1027] H. Ujike,et al. No association between the sigma receptor type 1 gene and schizophrenia: results of analysis and meta-analysis of case-control studies , 2003, BMC psychiatry.
[1028] J. Douglas Bremner,et al. Does stress damage the brain? , 1999, Biological Psychiatry.
[1029] E. Sigel,et al. The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABAA receptors , 2012, British journal of pharmacology.
[1030] K. Leenders,et al. Despite irreversible binding, PET tracer [11C]-SA5845 is suitable for imaging of drug competition at sigma receptors—The cases of ketamine and haloperidol , 2008, Neurochemistry International.
[1031] W. Hong,et al. Evidence that the sigma(1) receptor is not directly coupled to G proteins. , 2000, European journal of pharmacology.
[1032] R. Rupprecht,et al. Neurosteroids as Neuromodulators in the Treatment of Anxiety Disorders , 2011, Front. Endocrin..
[1033] M. Bujalska. Effect of nonselective and selective opioid receptors antagonists on antinociceptive action of acetaminophen [part III]. , 2004, Polish journal of pharmacology.
[1034] T. Mavlyutov,et al. Lack of sigma-1 receptor exacerbates ALS progression in mice , 2013, Neuroscience.
[1035] J. Musacchio,et al. SKF 525-A and cytochrome P-450 ligands inhibit with high affinity the binding of [3H]dextromethorphan and sigma ligands to guinea pig brain. , 1991, Life sciences.
[1036] P. Seeburg,et al. Transient expression shows ligand gating and allosteric potentiation of GABAA receptor subunits. , 1988, Science.
[1037] D. A. Meyer,et al. Neurosteroids Enhance Spontaneous Glutamate Release in Hippocampal Neurons , 2002, The Journal of Biological Chemistry.
[1038] W. Bowen,et al. Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor. , 1999, Biochemical pharmacology.
[1039] Yves Chaput,et al. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain , 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.
[1040] Sheila J. Jones,et al. Glutamate Does Not Play a Major Role in Controlling Bone Growth , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[1041] J G Brand,et al. Measurement of membrane potential and [Ca2+]i in cell ensembles: application to the study of glutamate taste in mice. , 1996, Biophysical journal.
[1042] S. Kulkarni,et al. The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice , 1998, Brain Research.
[1043] M. Fava,et al. An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses. , 2002, The Journal of clinical psychiatry.
[1044] David Attwell,et al. The glial cell glutamate uptake carrier countertransports pH-changing anions , 1992, Nature.
[1045] N. Farber,et al. Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity , 2002, Molecular Psychiatry.
[1046] A. Marrazzo,et al. Anti-amnesic and neuroprotective actions of the sigma-1 receptor agonist (-)-MR22 in rats with selective cholinergic lesion and amyloid infusion. , 2011, Journal of Alzheimer's disease : JAD.
[1047] S. Tam,et al. Autoradiographic identification and characterization of σ receptors in guinea pig brain using [3H]1(cyclopropylmethyl)-4-(2′-(4≈-fluorophenyl)-2′-oxoethyl) piperidine ([3H]DuP 734), a novel σ receptor ligand , 1992, Brain Research.
[1048] C. Chiueh,et al. Induction of Thioredoxin and Mitochondrial Survival Proteins Mediates Preconditioning‐Induced Cardioprotection and Neuroprotection , 2005, Annals of the New York Academy of Sciences.
[1049] M. Goldberg,et al. Hypoxic injury of isolated axons is independent of ionotropic glutamate receptors , 2007, Neurobiology of Disease.
[1050] Ernesto Estrada,et al. Order from chaos: observing hormesis at the proteome level. , 2005, Journal of proteome research.
[1051] M. Racchi,et al. Dehydroepiandrosterone (DHEA) and the aging brain: flipping a coin in the "fountain of youth". , 2003, CNS drug reviews.
[1052] Masahiko Watanabe,et al. Distinct gene expression of the N-methyl-d-aspartate receptor channel subunit in peripheral neurons of the mouse sensory ganglia and adrenal gland , 1994, Neuroscience Letters.
[1053] G. Pasternak,et al. Sigma binding in a human neuroblastoma cell line. , 1996, Neurochemical research.
[1054] K. Ogawa,et al. Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy , 2009, Cancer science.
[1055] M. DiFiglia,et al. Neuronal high-affinity glutamate transport in the rat central nervous system. , 1995, Neuroreport.
[1056] E. Roberts,et al. gamma-Aminobutyric acid in brain: its formation from glutamic acid. , 1950, The Journal of biological chemistry.
[1057] E. Meier,et al. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles. , 1995, Journal of medicinal chemistry.
[1058] J. Junien,et al. Selective stimulation of colonic motor response to a meal by σ ligands in dogs , 1990 .
[1059] J. Leysen,et al. Neuroprotective sigma ligands interfere with the glutamate‐activated NOS pathway in hippocampal cell culture , 1995, Synapse.
[1060] D. Johnston,et al. Dendritic calcium channels and hippocampal long‐term depression , 1996, Hippocampus.
[1061] T. Kameyama,et al. Role of (+)-SKF-10,047-sensitive sub-population of sigma 1 receptors in amelioration of conditioned fear stress in rats: association with mesolimbic dopaminergic systems. , 1997, European journal of pharmacology.
[1062] J. Son,et al. Chronic activation of sigma-1 receptor evokes nociceptive activation of trigeminal nucleus caudalis in rats , 2014, Pharmacology Biochemistry and Behavior.
[1063] J. Bormann. Electrophysiology of GABAA and GABAB receptor subtypes , 1988, Trends in Neurosciences.
[1064] Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine. , 2012, European journal of pharmacology.
[1065] R. Nicoll,et al. Presynaptic Kainate Receptor Mediation of Frequency Facilitation at Hippocampal Mossy Fiber Synapses , 2001, Science.
[1066] Shigetada Nakanishi,et al. Metabotropic glutamate receptors: Synaptic transmission, modulation, and plasticity , 1994, Neuron.
[1067] T. Skerry,et al. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[1068] S. Erdö. Excitatory amino acid receptors in the mammalian periphery. , 1991, Trends in pharmacological sciences.
[1069] G. Pasternak,et al. Sigma1 binding in a human neuroblastoma cell line , 1996, Neurochemical Research.
[1070] J. Vance,et al. Mechanisms of lipid-body formation. , 1999, Trends in biochemical sciences.
[1071] O. Pulido,et al. Subchronic toxicity study of domoic acid in the rat. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[1072] R. Wilke,et al. Membrane‐delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G‐protein nor ATP , 2000, The Journal of physiology.
[1073] K. Kurisu,et al. Primary neurotransmitters and regulatory substances onto vestibular nucleus neurons. , 2001, Uchu Seibutsu Kagaku.
[1074] S. Heinemann,et al. Cloned glutamate receptors. , 1994, Annual review of neuroscience.
[1075] H. Betz,et al. Structure and function of inhibitory glycine receptors , 1992, Quarterly Reviews of Biophysics.
[1076] A. Makhro,et al. Glutamate receptors modulate oxidative stress in neuronal cells. A mini-review , 2009, Neurotoxicity Research.
[1077] M. Hediger,et al. Primary structure and functional characterization of a high-affinity glutamate transporter , 1992, Nature.
[1078] K. Fukunaga,et al. Crucial interactions between selective serotonin uptake inhibitors and sigma-1 receptor in heart failure. , 2013, Journal of pharmacological sciences.
[1079] F. Werblin,et al. A glutamate-elicited chloride current with transporter-like properties in rod photoreceptors of the tiger salamander , 1996, Visual Neuroscience.
[1080] S. Homan,et al. Overexpression of sigma receptors in nonneural human tumors. , 1991, Cancer research.
[1081] T. Maurice,et al. Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[1082] K. Krishnan,et al. Clinical, demographic and social characteristics of psychotic depression , 1999, Psychiatry Research.
[1083] B. Dubrovsky. Neurosteroids, neuroactive steroids, and symptoms of affective disorders , 2006, Pharmacology Biochemistry and Behavior.
[1084] B. Duvilanski,et al. Glutamate induces apoptosis in anterior pituitary cells through group II metabotropic glutamate receptor activation. , 2004, Endocrinology.
[1085] A. Lajtha,et al. The effect of ibogaine on sigma- and NMDA-receptor- mediated release of [3H]dopamine , 1996, Brain Research Bulletin.
[1086] P. Celada,et al. Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors , 2001, The Journal of Neuroscience.
[1087] D. Lindquist,et al. Pregnenolone sulfate potentiation of NMDA-mediated increases in intracellular calcium in cultured chick cortical neurons , 1995, Brain Research.
[1088] E. D. De Souza,et al. Sigma-receptors in endocrine organs: identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary. , 1989, Endocrinology.
[1089] M. Pontecorvo,et al. Selective σ ligands block stimulant effects of cocaine , 1991 .
[1090] Teruo Hayashi,et al. Sigma-1 receptor chaperones and diseases. , 2009, Central nervous system agents in medicinal chemistry.
[1091] R. Miller,et al. The role of NMDA and non-NMDA excitatory amino acid receptors in the functional organization of primate retinal ganglion cells , 1994, Visual Neuroscience.
[1092] F. Weiss,et al. Effect of &sgr;1 receptor antagonism on ethanol and natural reward seeking , 2012, Neuroreport.